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Adolescents with type 1 diabetes (T1D) undergo psychological and physiological 
challenges that increase the risk for insulin sensitivity, diabetes-related distress, family-
conflict, and diabetes-related complications. Glycemic control, the cornerstone of 
management, is influenced by individual and familial factors. Most adolescents with T1D 
don’t achieve glycemic targets. This purpose of this research proposal is to describe an 
RCT with repeated-measures design, that will assess multi-dimensional family therapy for 
T1D (MDFT-T1D), an intervention that was designed specifically for adolescents with 
uncontrolled T1D. Adolescents (n=110) and a parent will be randomized to standard-care 
or MDFT-T1D and enrolled for 30-months. MDFT-T1D will consist of 8 in-person 
sessions at scheduled diabetes care appointments and intermediate check-in calls. RM-
ANOVA analyses will assess main outcomes of: Glycemic control, blood glucose 
monitoring, distress, and family conflict. 
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Type 1 Diabetes (T1D) is one of the most common chronic illnesses affecting youth in the 
United States (Pettitt et al., 2014). While T1D can develop at any age, three quarters of diagnoses 
occur in individuals younger than 18 years (ADA, 2018), which often places the burden of T1D 
management on parents and family members (Streisand & Monaghan, 2014). The American 
Diabetes Association (ADA) standards of care recommend parent or caregiver involvement in 
managing T1D throughout childhood (Chiang, Kirkman, Laffel, & Peters, 2014). 
While there is no cure for T1D, adhering to complex daily regimens designed to maintain 
glycemic control is considered the best way to decrease the likelihood of diabetes-related 
complications (DCCT/EDIC Research Groups, 2000; DCCT Research Group, 1994). Treatment 
regimens involve frequent blood glucose level checks, insulin administration via injection or 
pump, regulation of diet/physical activity, and constant vigilance by all involved in T1D care 
(Smaldone & Ritholz, 2011). In addition to dealing with a possibly traumatic T1D diagnosis (over 
50% hospitalized at diagnosis; Rewers et al., 2008), parents must quickly become experts in their 
child’s T1D care while simultaneously teaching others involved in their child’s life how to 
properly monitor and manage T1D. Parents report feeling isolated, overwhelmed, and stressed 
from tasks related to T1D care (Whittemore, Jaser, Chao, Jang, & Grey, 2012).  
During adolescence, the combination of hormonal and psychosocial changes, insulin 
resistance, and fluctuations in insulin need, increase the risk for mental health difficulties, diabetes-
related distress, and family conflict (Jaser, Yates, Dumser, & Whittemore, 2011). Positive family 
functioning characterized by open communication and low levels of conflict is critical in 
facilitating the transition of T1D care from caregiver to the adolescent (Anderson et al., 2002; 
Williams, Laffel, & Hood, 2009) and is associated with better adherence to daily regimens and 
better glycemic control (Hilliard et al., 2013). Conversely, high levels of diabetes-related family 
conflict and distress have been linked to poor adherence behaviors and poor glycemic control 
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(Lewin et al., 2006). It is especially concerning that only 21% of adolescents with T1D meet ADA 
HbA1c recommendations (Wood et al., 2013).  
Interventions have targeted different aspects of adherence to address poorly managed T1D 
and the impact of T1D on families, but few have demonstrated lasting effects on both 
family/psychosocial variables (family conflict and family distress) and glycemic control (Hood, 
Peterson, Rohan, & Drotar, 2009; Hood, Rohan, Peterson, & Drotar, 2010; Savage, Farrell, 
McManus, & Grey, 2010). Further, no interventions have been able to achieve widespread 
adoption into routine T1D care (Doherty, Calam, & Sanders, 2013). Systematic reviews indicate 
that the most successful interventions are guided by theory, target multiple aspects of diabetes 
management, and are easily integrated into routine care (Law, Fisher, Fales, Noel, & Eccleston, 
2014; Winkley et al., 2006).  
Interventions that specifically target the adolescent and their parent or caregiver offer the 
potential to increase family well-being, reduce family conflict, improve T1D health outcomes, and 
prevent future complications related to poor glycemic control (Hilliard et al., 2013; Hood et al., 
2010). Although family-based interventions have a long-standing history of support for their 
effectiveness in treating many challenging adolescent problems, family-based interventions for 
managing T1D have not been forthcoming. Multi-Dimensional Family Therapy (MDFT) is an 
evidence-based treatment developed for adolescent substance abuse that has been adapted for other 
high-risk adolescent populations. The multidimensional approach assumes that several pathways, 
contexts, and mechanisms impact adolescent and parent behavior. Thus, the approach targets these 
areas of life to yield significant and lasting change. MDFT fits well with the complexities of 
adherence and glycemic control in adolescents with T1D, but no published studies have assessed 
MDFT adapted for this population.  
The purpose of this proposal is to evaluate a randomized controlled trial (RCT) for an 
adapted version of MDFT designed for adolescents with poorly managed T1D (MDFT-T1D). 
MDFT-T1D is an intervention designed to be incorporated into routine diabetes management 
appointments for 24-months. Through eight in-person sessions plus bi-weekly phone calls, the 
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intervention targets social, emotional, and behavioral processes in adolescent-parent dyads to 
facilitate diabetes management, decrease diabetes-related conflict and distress, and influence 
short- and long-term health outcomes. This study will evaluate the efficacy of MDFT-T1D 
compared to a standard care (SC) condition in improving glycemic control, blood glucose 





The integrative analysis will provide a foundational understanding of diabetes including a 
description of biological underpinnings of T1D and type 2 diabetes (T2D), prevalence rates, 
potential complications (acute and chronic), and the challenges of daily living with diabetes. A 
rationale for exclusively targeting adolescents with poorly controlled T1D will also be provided. 
While there is extensive research across a variety of areas related to T1D, this review will focus 
on the multidimensional impact of T1D. The impact of T1D at the individual level (for both the 
T1D adolescent and their parent) and at the familial level (parent-adolescent interactions) with 
particular attention given to the impact of diabetes distress (DD), family functioning, and diabetes-
related conflict on T1D outcomes will be reviewed. Limitations of existing interventions will 
highlight the importance of targeting the entire family system and how an existing evidence-based 
intervention can be adapted for this population.  
TYPE 1 DIABETES 
Type 1 diabetes is an autoimmune disease characterized by a depletion of insulin-
producing cells (β-cells) that results in lifelong dependence on exogenous insulin (Chiang et al., 
2014). Glucose is the fuel that helps our bodies maintain the energy needed to stay alive (Mayo 
Clinic, 2018), and insulin is like the key that opens the door for glucose to enter the body. An 
individual with T1D still takes in energy through food, but without insulin, cannot absorb glucose 
into the body (Mayo Clinic, 2018). As a result, glucose builds up in the bloodstream, which 
overtime can lead to life-threatening complications including heart/blood vessel damage, 
neuropathy, nephropathy, retinopathy, skin conditions, and foot damage (Dabelea et al., 2018). 
While the exact cause of T1D remains unknown, there is evidence of genetic predispositions for 
T1D and strong (but circumstantial) evidence of environmental factors that trigger β-cell 
destruction (Patterson et al., 2014; Vehik & Dabelea, 2011). 
Once known as “juvenile diabetes” (Mayo Clinic, 2018), T1D was thought to be the 
exclusive form of diabetes in youth (Nadeau & Dabelea, 2008). However, there has been a recent 
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surge in the rates of T2D diagnosed in youth (Chiang et al., 2014). T2D has a more gradual onset 
than T1D in youth and the risk for developing T2D increases with age (Nadeau & Dabelea, 2008). 
T2D involves the development of muscle and tissue resistance to insulin which eventually leads 
to greater insulin requirements for the body to maintain healthy glucose levels (Mayo Clinic, 
2018). While the ADA outlines identical diagnostic criteria for T1D and T2D (2018) and reports 
similar medical complications (for example, hyperglycemia), the pathophysiology and etiology of 
the two diseases are distinct warranting the independent consideration of each (Maahs et al., 2010). 
The focus of this review and research proposal is on T1D. 
Prevalence 
In 2015, 30.3 million Americans, or 9.4% of the population, had a diabetes diagnosis 
(CDC, 2017). The prevalence of T1D and T2D has been steadily rising in the US (Mayer-Davis et 
al., 2017; Patterson et al., 2014). Presently, T2D accounts for 90-95% of diabetes cases (Mayo 
Clinic, 2018), but in the 0–19 year age group 79% of new diabetes diagnoses are for T1D 
(Imperatore, Mayer-Davis, Orchard, & Zhong, 2018). Worldwide, it has been estimated that 
79,100 children under the age of 15 years develop T1D each year (Guariguata et al., 2014). The 
SEARCH for Diabetes in Youth Study (The SEARCH Study Group, 2004) was developed in 2001 
to assess overall prevalence and incidence of diabetes in American youth under 20 years. Research 
from this group estimated that 18,436 U.S. youth1 were newly diagnosed with T1D in 2009 
(Lawrence et al., 2014) and one in every 518 (1.93 per 1,000) youth, approximately 0.25% of the 
youth population, had T1D (Pettitt et al., 2014). T1D appears to be more common in Non-Hispanic 
white youth (Dabelea et al., 2014), although more recent estimates show that T1D has significantly 
increased in Hispanic youth (Mayer-Davis et al., 2017). T2D has a history of disproportional 
impact on minority youth (NIDDK, 2018).  
 
1 Breakdown of the 18,436 youth with T1D in 2009: 12,945 non-Hispanic white, 3,098 Hispanic, 2,070 non-
Hispanic black, 276 Asian-Pacific Islander, and 47 American Indian. 
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Signs and Symptoms 
Signs and symptoms of T1D often develop quickly, but there is tremendous variability in 
how it presents at the time of diagnosis (Chiang et al., 2014; Maahs et al., 2010; Wood, 2018). 
Clinical symptoms suggestive of insulin deficiency include polyuria (increased volumes of dilute 
urine), polydipsia (increased thirst), weight-loss, lethargy, irritability or behavior change, and 
fruity-smelling breath (Chiang et al., 2014; Maahs et al., 2010; Mayo Clinic, 2018). While large-
scale efforts in the U.K. have increased awareness to the “4 T’s” (Wood & Peters, 2018) - Toilet, 
Thirsty, Thinner, Tired - symptoms suggestive of T1D are often not immediately recognized in the 
US (Klingensmith et al., 2013; Wood & Peters, 2018), especially for children younger than four 
and those of lower SES (Maniatis et al., 2005). In the US, 54% of youth with T1D are hospitalized 
upon diagnosis and 25.5% present with severe Diabetic Ketoacidosis (DKA) (Rewers et al., 2008), 
a condition that can lead to diabetic coma or death (ADA, 2015). Due to unexpected medical 
attention that newly diagnosed youth often require, families rarely have a chance to emotionally 
process or prepare for the challenges that T1D brings (Smaldone & Ritholz, 2011).    
LIVING WITH DIABETES 
Disease Management and Standards of Care 
Effective management of T1D requires considerable time, effort, and extreme coordination 
and cooperation by the entire family, the T1D care team, and any others that play a role in the 
youths’ life (Freeborn, Dyches, Roper, & Mandleco, 2013). Immediately after diagnosis, an 
individual diagnosed with T1D will need an individualized care plan with ongoing education and 
support, regular assessment for acute and chronic complications, and access to medical providers 
with expertise in T1D (Chiang et al., 2014). Parenting a child with any chronic or life-threatening 
illness can present significant challenges (Eccleston et al., 2015) and many parents of youth with 
T1D struggle to adjust to the unexpected T1D diagnosis (Palmer et al., 2011). Some parents report 
feeling unprepared and overwhelmed with the responsibility of caring for their child (Whittemore 
et al., 2012). Coordination and cooperation from the entire family and the systems (school, friends, 
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extracurricular activities) that surround the youth is essential (Palmer et al., 2011). Main indicators 
of T1D control and management, standards of care, disease outcomes, and complexities of T1D 
during adolescence are summarized in the following sections.  
The management and control of T1D in youth is not a one person job; it requires active 
participation at the individual and family level, and often the involvement of a multidisciplinary 
team of specialists sensitive to the challenges of T1D management (ADA, 2018). Aspects of care 
unique to youth with T1D such as insulin sensitivity related to physical growth and sexual 
maturity, constant change in ability to provide self-care, variable supervision that depends on the 
environment (home, child care or school), neurological vulnerability to hypoglycemia and 
hyperglycemia, and possible adverse neurocognitive effects of DKA (Cameron et al., 2014), 
warrant regular attention by diabetes health teams (ADA, 2018; ADA, 2017). Routine T1D visits 
generally occuring on a quarterly basis should include: a review of self-monitoring of blood 
glucose levels (BGL), continuous glucose monitoring (CGM) and pump data (if applicable), 
HbA1c measurement, checks for evidence of acute and/or chronic complications of diabetes 
(particularly episodes of DKA and mild and/or severe hypoglycemia), measurement of blood 
pressure and weight (and height in children), a foot exam, inspection of injection/ insertion sites, 
and a discussion of patients’ psychosocial and educational needs (Chiang et al., 2014).  
The Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes 
Interventions and Complications (EDIC) follow-up study demonstrated the benefits of intensive 
therapy for the management of T1D and established many standards of care that are used to manage 
outcomes in youth (DCCT/EDIC Research Group, 2001; DCCT Research Group, 1994). Intensive 
insulin therapy, which includes the use of basal-bolus regimens, insulin pumps, frequent blood 
glucose monitoring, goal setting, and patient education in management from diagnosis to 
adolescence (ADA, 2018) is necessary. Intensive insulin management was found to be associated 
with more children reaching blood glucose targets (ADA, 2018) and has heavily influenced 
standards of care for T1D. It can be difficult for families to adhere to these management 
recommendations (Hauser et al., 1990). 
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Glycemic control is a cornerstone of T1D management, and current diabetes care standards 
stress the need to lower glucose levels in T1D youth as safely as possible using stepwise goals 
(ADA, 2018). To monitor and inform management goals and maintain glycemic control in T1D, 
two criticial physiological measures, BGL and HbA1c, are collected and interpreted at regular 
diabetes care appointments (Chiang et al., 2014). The ADA recommends that all children and 
adolescents with T1D self-monitor their BGL (ADA, 2018) which requires six to ten checks daily 
(Chiang et al., 2014). It is recommended to check BGLs before (and possibly after) meals, at 
bedtime, before and after exercise, before driving, and when experiencing symptoms of 
hypoglycemia (pale complexion, sweating, shakiness, lethargy, loss of coordination) (ADA, 2018; 
Chiang et al., 2014). The most common method of monitoring glucose is through the use of a 
blood glucose meter (Harris, Hood, & Mulvaney, 2012), which uses a small amount of blood 
obtained via fingerstick that is entered onto a glucose test strip to measure glucose concentration 
(Clarke & Foster, 2012). With this information, insulin can be dosed to meet the body’s needs and 
injected via shot. Additional “self-care” (Dashiff, McCaleb, & Cull, 2006) diabetes tasks include 
dietary monitoring, insulin adjustment (especially during physical activity) and preparedness for 
hyperglycemia (Hanson et al., 1996).  
HbA1c reflects an average of glycemia over 2-3 months (Sacks et al., 2011) and can be 
used to track glycemic control over time. The ADA, International Society for Pediatric and 
Adolescent Diabetes (ISPAD), and Pediatric Endocrine Society have harmonized their HbA1c 
goal, and recommend that all pediatric age-groups maintain an HbA1c <7.5% (ADA, 2018, 2017; 
ISPAD, 2011). This recommendation stems from associations between high HbA1c and 
hypoglycemia and DKA (Ly et al., 2014) and long-term health complications (Rewers et al., 2014). 
There is also evidence that HbA1c varies by race/ethnicity (Borschuk & Everhart, 2015; Wang et 
al., 2017), age (Bryden et al., 2001; Miller et al., 2015), and SES (Zuijdwijk, Cuerden, & Mahmud, 
2013); making it important to consider multiple indicators of glycemic control and adherence when 
evaluating management of T1D in youth. While there have been clear advances in standard 
medical regimens for management and control of T1D in youth, these techniques can only be 
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effective with compliance from the youth and their family (ADA, 2018; Miller et al., 2015). This 
typically is not accomplished by adolescents with T1D (Miller et al., 2015).  
Disease Outcomes 
With a peak age of onset between 10-14 years, youth diagnosed with T1D are impacted for 
the majority of their lifetime, and therefore, are more likely to develop diabetes-related 
complications (Imperatore, Mayer-Davis, Orchard, & Zhong, 2018). Outcomes from DCCT and 
several additional studies have demonstrated that intensive insulin therapy can delay onset and 
slow progression of diabetes-related complications (DCCT Research Group, 1994; Fullerton et al., 
2014; Genuth, 2006); however, rates of short-term complications in youth with T1D remain high, 
even with intensive insulin therapy (Levine et al., 2001). In fact, data extracted from the T1D 
Exchange Clinic Network, one of the largest registries of pediatric endocrinology practices in the 
US, reported that only 21% of adolescents between 13 and 20 years met ADA standards for HbA1c 
(Wood et al., 2013). Deterioration of adherence behaviors (Borus & Laffel, 2010; Datye, Moore, 
Russell, & Jaser, 2015) and glycemic control specifically during adolescence (Cravedi, 
Ruggenenti, Remuzzi, & Remuzzi, 2014) is well documented. Evidence from the EDIC follow-up 
study to the DCCT also showed that poor control of T1D youth can leave lasting damage (Barnard, 
Thomas, Royle, Noyes, & Waugh, 2010). 
Uncontrolled blood sugar levels, which could be the result of insufficient blood glucose 
monitoring frequency (BGMF), too much or too little insulin dosage administration, or poor 
diet/lifestyle habits, are more likely to lead to acute complications in youth with T1D (Dabelea, 
Hamman, Knowler, 2018). The most common acute conditions seen include hyperglycemia (high 
blood sugar), hypoglycemia (low blood sugar), and DKA (Dowshen, 2018). When severe, 
hypoglycemia and DKA can both be life-threatening (Edge, Hawkins, Winter, & Dunger, 2001; 
Rewers et al., 2002, 2008) and can lead to fear and distress in the youth with T1D and their family 
(Barnard et al., 2010; Patton, Dolan, Smith, Thomas, & Powers, 2011). DKA is the consequence 
of severe insulin deficiency that leads to accumulation of ketone bodies in the blood and 
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subsequent metabolic acidosis (Silverstein et al., 2005). DKA is the most common reason for 
hospitalization of youth with T1D (Harris et al., 2014). Cerebral edema, a complication of DKA, 
is a leading cause of mortality among youth with T1D (Edge et al., 2001).  
In addition to an increased risk for premature death and lower quality of life in T1D youth, 
DKA and severe hypoglycemia impose large economic burdens on the health care system 
(Shrestha, Zhang, Barker, & Imperatore, 2010; Wolfsdorf et al., 2009). The mean annual total 
medical expenditures for youth with and without DKA were $14,236 and $8,398, respectively 
(Shrestha et al., 2010). Some youth with T1D are at higher risk for experiencing acute 
complications such as DKA and hypoglycemia. It has been suggested that those who are uninsured, 
present with higher HbA1c levels, and/or have psychiatric disorders, should be targeted in 
interventions (Rewers et al., 2002; Skinner, 2002). There is additional evidence that youth with 
less support from caregivers and more diabetes-related conflict at home experience additional risk 
for health complications (Geffken et al., 2008).  
Complexities of Management During Adolescence 
At each stage of growth and development, youth with T1D face different challenges that 
dictate the standards of care (Chiang et al., 2014; Jaser et al., 2012). The consequences of poor 
glycemic control differ drastically throughout development and the risk of experiencing acute 
complications is influenced by puberty (Chiang et al., 2014; Silverstein et al., 2005) The transition 
into adolescence is marked by improvements in cognition and problem solving (Dahl, 2004), 
considerable hormonal and psychological changes (Datye et al., 2015), and new desires for 
independence – which often lead to increased risk taking, sensation seeking, and reckless behavior 
(Dahl, 2004; Jaser et al., 2011). An interesting dilemma exists for adolescents with T1D: the 
physiological changes make blood glucose control more difficult and warrant increased vigilance 
to diabetes management tasks, but the psychosocial changes, new desire for independence, and 
inclination towards risk taking stand counter to effective management (Borus & Laffel, 2010). The 
suboptimal glycemic control that commonly occurs during adolescence (Mayer-Davis et al., 2017; 
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Miller et al., 2015; Eilander et al., 2015) may be attributed to this combination of physiological 
and psychological change.   
In addition to disrupting adherence to diabetes care regimens, the hallmarks of normal 
adolescent development can lead to heightened parent-adolescent conflict, which can be especially 
problematic while renegotiating roles in T1D management (Young-Hyman et al., 2016). 
Adolescence is a critical period for establishing lifelong positive and risky health-related 
behaviors, so parents walk a fine line when shifting diabetes management responsibilities to their 
adolescent. There is strong evidence that parents who can reduce diabetes-related conflict (Miller-
Johnson et al., 1994) and maintain their involvement in the T1D care will have adolescents with 
better adherence behaviors and glycemic control (Landers, Friedrich, Jawad, & Miller, 2016). 
Additional evidence suggests that miscarried helping, which is a maladaptive interaction pattern 
in which a parent attempts to assist with T1D management is common during adolescence and can 
result in increased conflict, resistance, and ultimately parental withdrawal from assistance with 
disease management (Duke, Wagner, Ulrich, Freeman, & Harris, 2016).  
MULTIDIMENSIONAL IMPACT OF TYPE 1 DIABETES 
It is helpful to adopt an ecological perspective (Bronfenbrenner & Morris, 2007) when 
considering the impact of T1D. From this perspective, the intersecting web of social influences is 
believed to form the context of human development. When applied to youth with T1D, one could 
predict that both intrapersonal and interfamilial processes affect and are affected by the system 
surrounding the youth. Similarly, in family systems theory, the family is viewed as a system 
composed of interrelated parts (Broderick, 1993). From this perspective, a problem for any 
member of a family has an effect on all others and changes in any member result in adaptations 
among all other family members. T1D requires adjustments by all family members as they attempt 
to meet changing demands associated with illness onset, disease development, day-to-day 
management, and complications. When a child is diagnosed with T1D there are overwhelming 
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implications for the child, their caregivers, and the interactions between the child and caregivers 
(Whittemore et al., 2012).  
 Parents often express significant anxiety over future complications (Landolt et al., 2002) 
and are overwhelmed with significant changes to their daily life (Whittemore et al., 2012). The 
significant changes that families of T1D youth must make lead to high levels of diabetes related 
distress. Concerns about acute complications such as hyperglycemia and DKA can lead to constant 
worry and hypervigilance to diabetes management regimens that can cause parent-child conflict 
that negatively affect T1D health outcomes (Kovacs, Goldston, Obrosky, & Iyengar, 1992; Lewin 
et al., 2005). While there is great importance to maintaining glycemic control and adhering to 
diabetes care regimens, the distress and conflict that is activated among those involved in the care 
of  T1D youth should not be overlooked in interventions for this population (Datye et al., 2015). 
Issues of adherence in adolescents with T1D appear to be multidimensional (Liddle, 2016) with 
individual, biological, social, interpersonal, familial, developmental, and social ecological aspects 
that contribute to the development, continuation, and worsening of adherence behaviors and 
glycemic control.  
Individual Level Considerations 
In addition to physiological complications that can occur when T1D is poorly controlled, 
the psychological impact of T1D can cause significant distress and present additional barriers to 
optimal management (Butwicka et al., 2015; Dybdal et al., 2018; Johnson, Elliott, Scott, Heller, & 
Eiser, 2014). A recent study found that general distress and distress related to diabetes is common 
(50%) in adolescents with T1D; and both kinds of distress were found to be significantly associated 
with higher HbA1c, poorer self-management activity, and lower quality of life (Rechenberg, 
Whittemore, Holland, & Grey, 2017). Diabetes distress (DD) refers to the negative emotions 
arising from living with diabetes and the burden of self-management (Hagger, Hendrieckx, Sturt, 
Skinner, & Speight, 2016; Kreider, 2017) and is commonly used as an outcome measure in 
interventions for T1D (Hagger et al., 2017; Polonsky et al., 1995). Elevated DD has been observed 
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in about one third of adolescents with T1D and is associated with suboptimal glycemic control 
(Bernstein, Stockwell, Gallagher, Rosenthal, & Soren, 2013; Powers, Richter, Ackard, & Craft, 
2017), low self-efficacy and reduced self-care (Hagger et al., 2016), increased risk for anxiety and 
depressive symptoms (Herzer et al., 2011) , poor coping and problem solving (Grey, Boland, 
Davidson, et al., 1998; Wysocki, Iannotti, et al., 2008), and family conflict (Anderson et al., 2002). 
DD is thought to be a result of a combination of the medical and psychological burden of 
management, and has been found to create emotional distress that often remains hidden from 
providers (Tareen & Tareen, 2017). While DD may look similar to depression, which is more than 
three times as prevalent in youth with T1D than youth without (Grey, Whittemore, & Tamborlane, 
2002), it is considered a different condition that warrants different treatment.  
For parents, the sudden shock of diagnosis and instant responsibility of managing their 
child’s T1D (Landolt et al., 2002, 2005), the constant worry, and feelings of responsibility for the 
health of their child (Lowes et al., 2015) all contribute to stress in parents of youth with T1D. 
Qualitative research shows that many parents rearrange their schedules to care for their child with 
T1D full-time and experience disruptions in the parent-child relationship due to the need for them 
to control and supervise their child in new ways (Whittemore et al., 2012). The psychological 
experience of parents has been extensively studied in the context of child chronic illness (Eccleston 
et al., 2015) and pediatric T1D (Whittemore et al., 2012). Parents of youth with T1D are also at 
increased risk for depression, anxiety, and disease-specific indicators of well-being such as DD, 
pediatric parenting stress, and fear of hypoglycemia (Moreira, Frontini, Bullinger, & Canavarro, 
2014; Streisand & Monaghan, 2014). Parental DD has been found to significantly predict youth 
illness uncertainty (Mullins et al., 2007), lower family satisfaction (Moreira et al., 2014), and 
poorer communication about diabetes-related responsibilities (Wysocki, 1993). A bidirectional 
relationship between diabetes and emotions is well established (Chew, Shariff-Ghazali, & 
Fernandez, 2014; Williams et al., 2009) and while positive psychological health in parents is a 
protective factor for T1D health outcomes (Eilander et al., 2017; Sweenie, Mackey, & Streisand, 
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2014), psychological distress predicts increased diabetes specific family conflict (Williams et al., 
2009) and poorer adherence to T1D monitoring behaviors (Miller-Johnson et al., 1994).  
Familial Level Considerations 
Many of the barriers and facilitators of T1D management are psychosocial in nature (Datye 
et al., 2015) and family conflict in particular has consistently been one of the strongest predictors 
of long-term adherence outcomes in adolescents with T1D (Anderson et al., 2002; Moore, 
Hackworth, Hamilton, Northam, & Cameron, 2013; Wysocki, 1993). During adolescence, conflict 
with parents is developmentally normal and expected (Viikinsalo et al., 2005), but in adolescents’ 
with T1D, this conflict can detrimentally impact health outcomes (Anderson et al., 2002). Family 
environments characterized by conflict and poor cohesion may be linked with metabolic control 
directly (through physiological reactions to anger or distress) or indirectly through poor adherence 
(Miller-Johnson et al., 1994). Diabetes-specific family conflict has been found to have an additive 
and independent contribution to glycemic outcomes, accounting for 6% of the variance in HbA1c 
(Hood, Butler, Anderson, & Laffel, 2007). A combination of diabetes-related family factors, 
adherence, and metabolic control accounted for 34% of the variance in metabolic control (Lewin 
et al., 2006). 
ADDRESSING COMPLEXITIES OF TYPE 1 DIABETES MANAGEMENT 
A substantial amount of research demonstrates that physiological, behavioral, and 
psychological factors play a role in the management of T1D during adolescence. National and 
International diabetes organizations (ISPAD, 2011; Young-Hyman et al., 2016) acknowledge the 
impact of psychosocial factors on diabetes self-care and have called for the integration of regular 
screening and intervention into routine diabetes care appointments. Despite the recommendations 
and documented benefit of psychosocial intervention (Hampson et al., 2001; Hilliard, Powell, & 
Anderson, 2016), behavioral health integration is not yet a standard practice in the US (Barry, 
Johnson, & MacGregor, 2018)  While barriers to integrating behavioral health care specialists into 
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standard care for youth with T1D are outside of the scope of this review, many have acknowledged 
the growing need to integrate psychologists with training in T1D and evidenced-based intervention 
directly into clinics serving families of youth with T1D (Hunter, 2016).  
Interventions for Improving Health Outcomes in Type 1 Diabetes 
Interventions developed for youth with T1D have focused on improving the psychological 
and behavioral variables that influence glycemic control and self-care/adherence behaviors 
(Hilliard et al., 2016). The theoretical framework, delivery format and setting, selected population, 
and primary targets of interventions for youth with T1D have been diverse. Randomized controlled 
trials (RCTs) developed to improve adherence, medical outcomes, and mental health outcomes 
tend to utilize interventions that group into at least one of four broad categories (Hilliard et al., 
2016): 1) Skills Training Programs (Ambrosino et al., 2008; Fisher et al., 2013; Margaret Grey, 
Boland, Davidson, Li, & Tamborlane, 2000); 2) Multisystemic Interventions (Ellis et al., 2005, 
2008; Harris et al., 2015), 3) Family Interventions (Jaser, Patel, Rothman, Choi, & Whittemore, 
2014; Satin, Greca, Zigo, & Skyler, 1989; Svoren, Butler, Levine, Anderson, & Laffel, 2003; 
Wysocki et al., 2007, 2008), and 4) Technology and “mHealth” interventions (Cafazzo, 
Casselman, Hamming, Katzman, & Palmert, 2012; Hackworth et al., 2013; Harris et al., 2012; 
Wagner et al., 2016). 
Educational interventions (Winkley et al., 2006) have produced insignificant effects on 
glycemic control. (Murphy, Rayman, & Skinner, 2005). Behavioral interventions tend to focus on 
tasks related to T1D management such as BGMF, diet modification, and lifestyle changes 
(Harkness et al., 2010). A meta-analysis of behavioral interventions for diabetes (Hampson et al., 
2000) found that only a small number of interventions reported sufficient detail to permit the 
calculation of effect sizes. Together, educational and behavioral interventions have small to 
medium beneficial effects on various diabetes management outcomes (Hampson et al., 2001). 
Psychological interventions tend to be more varied and may include aspects of CBT, family 
therapy, communication skills training, coping skills training, problem solving, social support, and 
 
 16 
relaxation. Systematic reviews and meta-analyses conclude that psychological interventions have 
only modest influences on Quality of Life (QoL), adherence behaviors, and glycemic control, with 
effect sizes in the small to medium range (Harkness et al., 2010; Harvey, 2015; Hood et al., 2010; 
Law et al., 2014). A more recent systematic review (Eccleston et al., 2015) of psychological 
interventions for youth with chronic illnesses reported that psychological interventions developed 
for youth with diabetes have only a small beneficial effect on improving glycemic control at post 
treatment; these effects were maintained at follow-up.  
Reviews of interventions developed for adolescents with T1D (Hampson et al., 2001; Hood 
et al., 2010; Winkley et al., 2006) suggest that the most successful interventions with larger effect 
sizes are guided by theory, target multiple aspects of diabetes management, and are easily 
integrated into routine care (Hood et al., 2010; Law et al., 2014; Winkley et al., 2006). Given the 
known associations between family functioning, family conflict, adherence, and glycemic control, 
it is not surprising that many interventions have targeted the family system; however, outcomes 
stemming from family-focused interventions for youth with T1D have been inconsistent. A review 
of several interventions developed to target adolescents with poorly managed T1D can help explain 
the small to moderate effect sizes.     
While most interventions targeting adolescents with T1D collect at least one behavioral 
indicator of adherence (e.g. BGMF) and a measure of HbA1c, additional outcome variables vary, 
and usually reflect the nature of the intervention. The majority of research teams acknowledge the 
significant role of family in T1D outcomes, but many RCTs focus intervention efforts solely on 
improving glycemic outcomes (Abualula, Jacobsen, Milligan, Rodan, & Conn, 2016). For 
example, motivational interviewing (MI) conducted with adolescents in the U.K. (Channon et al., 
2007) found that after an average of six sessions (over 12-months), adolescents with T1D who 
received the MI had improved QoL and significantly reduced HbA1c (Channon et al., 2007). MI 
components varied from patient to patient in this RCT, but tended to include: awareness building, 
cost/benefit analysis of behaviors, problem solving, goal setting, and the avoidance of 
confrontation (Channon et al., 2007; Christie & Channon, 2005). While the reductions in HbA1c 
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were promising, the intervention was limited by a homogeneous (100% Caucasian) and small 
sample group, and because the research team did not control for T1D care, the changes in HbA1c 
may have been the result of care being received elsewhere (Channon et al., 2007).  
Similarly, in the ABCs of Diabetes Study (Adolescents Benefit from Control of Diabetes), 
both metabolic and psychosocial outcomes in adolescents with T1D were targeted through a 
behavioral coping skills training (CST) program (Grey et al., 2000). Adolescents with a recent 
HbA1c reading above ADA recommendations, received 12-months (six weekly sessions followed 
by monthly sessions) of CST in small groups. The CST intervention trained adolescents in 
appropriate and constructive coping styles through role play activities that simulated difficult 
situations faced by adolescents with T1D. Compared to adolescents who received only intensive 
diabetes management, adolescents who received CST showed significantly greater reductions in 
HbA1c from baseline to mid-treatment and from baseline to 12-month measurement (Grey et al., 
2000). Importantly, this study showed that HbA1c can be significantly improved (and approach 
ADA recommended levels) when intensive insulin management regimes are coupled with CST. 
While the authors claimed that skills learned in CST help adolescents negotiate with family 
members and potentially reduce conflict (Grey et al., 2000), the impact of CST on family 
functioning was not measured.  
Ellis et al. (2004, 2005) adapted Multisystemic Therapy (MST), a treatment model 
originally used for youth with delinquent behaviors, for adolescents with chronically poor 
glycemic control (an average HbA1c greater than or equal to 8% for at least the past 6-months). 
The intensive, home-based treatment model of MST encompasses the individual adolescent, the 
family system, and the broader community systems within which the family operates, making it 
an excellent fit with the known etiology of severe adherence problems in adolescents with T1D 
(Ellis et al., 2004). Findings from RCTs indicated that compared to a SC group, adolescents who 
received MST showed significant increases in BGMF and significant reductions in hospital 
admissions (Ellis et al., 2005). Intent-to-treat analyses showed only trends towards significant 
reductions in HbA1c; though adolescents who received a “significant dose” of MST showed an 
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average HbA1c decline of 0.8% (D. A. Ellis et al., 2005). The mean number of sessions for 
intervention completers was higher than any other intervention reviewed (Average number of 
sessions = 48, SD 19), and treatment intensity (number of sessions) differed among participants. 
It is hard to determine how similar (or different) the treatment - which is guided by 9 treatment 
principles (Ellis et al., 2004) - was between participants. While the therapists drew upon a “menu 
of evidence-based intervention techniques”, refining this type of intervention to be ready for 
implementation in routine diabetes care would prove to be difficult. The authors noted that the 
intensive nature of the treatment requires therapists to have low caseloads and high availability, 
which makes replication of MST for T1D youth difficult for many clinics (Ellis et al., 2005, 2004). 
While the MST model recognizes the influence of family on adolescent functioning, no measure 
of family functioning was reported. 
Behavioral Family Systems Therapy for Diabetes (BFST-D) was developed over 15 years 
ago by Wysocki et al. (2000) and has since been refined and adapted to better address the 
challenges that families with diabetic youth experience (Duke et al., 2008; Harris, Freeman, & 
Beers, 2009; Harris, Freeman, & Duke, 2015; Wysock et al., 2008). BFST-D is considered a well-
established intervention that has been used with adolescents displaying poor glycemic control or 
high levels of family conflict (Wysocki et al., 2008). Wysocki and colleagues updated BFST-D 
(2006) making adjustments to better address glycemic control and treatment adherence, which 
were not significantly impacted in earlier trials (Wysocki et al., 2000). Presently, BFST-D consists 
of four components: (1) problem-solving training, (2) communication training, (3) cognitive 
restructuring, and (4) functional-structural family therapy (Wysocki, 2006; Wysocki et al., 2007; 
Wysocki et al., 2008). In most adaptations, families receive 12 BFST-D sessions over 6 months, 
conducted by a single licensed psychologist (Wysocki, 2006). All sessions include didactic 
information and emphasis on a particular skill for the family to apply at home. With adaptations 
that target challenges specific to diabetes, adolescents and families who received BFST-D showed 
significant reductions in family conflict and significantly greater improvements in adherence when 
compared to educational support and standard care groups (Wysocki, 2006; Wysocki et al., 2008). 
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Changes in HbA1c were similar across families randomized to the BFST-D group and the 
educational support group (Wysocki, 2006). Follow-up analyses indicated that benefits in family 
conflict and adherence dissipated over time (Wysocki et al., 2007).  
More recent studies (Duke et al., 2016) have demonstrated the feasibility and efficacy of 
BFST-D administered via telehealth. The structured, directive, skills-based nature of BFST-D may 
help explain the similar outcomes across the clinic-based and telehealth groups (Duke et al., 2016); 
although it is important to note that this RCT lacked a control condition, so results must be viewed 
cautiously. While there is good evidence for the effectiveness of BFST-D in RCTs, there is no way 
to know how effective (or feasible) it would be if delivered in “real-world” conditions. Further, 
Wysocki et al. (2007) explicitly noted that the RCTs for BFST-D have been “conducted under 
optimal circumstances that are unlikely to exist in typical clinic settings,” and admit that future 
studies should focus on optimizing its feasibility and reducing the number of sessions (Wysocki et 
al., 2007). 
While there are substantial benefits of integrating low-cost, low-intensity interventions into 
routine T1D care (Anderson, Brackett, Ho, & Laffel, 1999), there is inconsistent evidence 
supporting the effectiveness of office-based interventions. An office-integrated, family-focused 
teamwork intervention that focused on improving adherence in a large sample of T1D youth found 
that problem-solving training, parent involvement in T1D management, and setting realistic 
expectations for T1D care did not significantly impact glycemic outcomes (Katz, Volkening, 
Butler, Anderson, & Laffel, 2012). This study reported that the intervention failed to produce a 
significant impact on glycemic outcomes. More promising results have been reported for the WE-
CAN Manage Diabetes Intervention (Nansel et al., 2012). The intervention was guided by 
recognition that diabetes outcomes (glycemic control, treatment adherence, quality of life, and 
mental health) are influenced by both parent and child factors. A multi-center RCT with families 
of youth with T1D tested the effect of this intervention with HbA1c and BGMF as the primary 
outcomes. A significant intervention-by-age interaction revealed significantly greater treatment 
effects on the older group (12-15 years) of T1D youth (Nansel et al., 2012). Findings from this 
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study reveal the feasibility of integrating family focused behavioral management intervention into 
ongoing T1D care, and the utility of this type of intervention especially for youth beginning to take 
greater responsibility in their T1D management (Nansel et al., 2012). 
While interventions have included parents (at varying degrees), most have focused 
intervention efforts on the adolescent alone and have failed to address parent factors that could 
uniquely contribute to deteriorating medical outcomes. Eccelston and colleagues (2016) noted that 
"It is surprising how few trials have targeted parent behavior or mental health, given the 
longstanding interest of psychologists in understanding the relationship between child and parent 
adjustment to chronic illness” (Eccelston et al., 2016, p. 25).  It is possible that reducing parent-
specific barriers to assisting their adolescent in T1D care could increase effectiveness of 
interventions. Whittemore et al. (2012) conducted a systematic mixed-studies review of research 
pertaining to the parental psychological adjustment of having a child with T1D. Across reviewed 
studies, 33.5% of parents reported distress at diagnosis, and 19% reported distress one to four years 
after diagnosis. Adults also must learn to cope with the daily struggles and learn to manage their 
child’s T1D, but without psychological support, they may be more vulnerable to DD and additional 
mental health conditions. As previously described, parental DD has been found to be associated 
with family dysfunction and often negatively impacts diabetes management and health outcomes. 
Interventions that support both the adolescent and their parents may be a powerful way to more 
fully treat the entire system surrounding an adolescents’ with T1D. 
MULTIDIMENSIONAL FAMILY THERAPY (MDFT) 
Issues of noncompliance to medical regimen are multiply determined and necessitate a 
multifaceted approach (Hood et al., 2010). An ecological theory recognizes reciprocal nature of 
human relationships and conceptualizes an adolescent’s poorly controlled T1D as a problem that 
nests at different levels. Thus, from this perspective effective interventions must address the 
multiple levels of poor glycemic control in adolescents.  
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MDFT is a comprehensive, developmentally oriented, family-centered treatment that was 
originally developed for youth substance abuse and delinquent behaviors (Liddle, 1991). It has 
been recognized as a well-established and empirically supported treatment for these problems 
(Liddle, 2016) and has been implemented with youth and families in the US and abroad, from 
diverse ethnic, racial, and SES backgrounds (Rowe, Liddle, Dakof, & Henderson, 2009). The 
multidimensional approach assumes that several pathways, contexts, and mechanisms impact the 
development of maladaptive behaviors and targets all of them in order to produce lasting change 
(Liddle, 2013).  Specifically, MDFT focuses on the adolescent as an individual, parent(s) as an 
individual(s) or as a subsystem, family interactional system, and the family members’ interactions 
with outside systems (Liddle, 2016). The adolescent and parent(s) are viewed as both wholes and 
parts, “each is a realm of life activity, offers clinical relevance, and intervention potential in and 
of itself, but each is also understood in relation to and in real-time interaction with the others” 
(Liddle, 2016). 
MDFT is both a tailored and flexible treatment that can be adapted to meet the needs of the 
youth and family being served. The treatment is typically delivered in 60-90 minute weekly 
sessions over a three to six month period with additional case management services and phone 
calls (Rowe & Liddle, 2018). Treatment is divided into three phases: Phase (1) Building a 
foundation for change, Phase (2) Facilitating individual and family change, and Phase (3) Solidify 
changes and launch. Throughout the intervention, therapists meet alone with the adolescent, alone 
with the parent(s), and jointly with the adolescent and parent(s). All intervention components are 
developmentally sensitive and enhance individual and family skills. The ten guiding principles of 
MDFT (see Appendix A) provide a framework for therapists. 
Conceptual Framework for MDFT-T1D 
As previously noted, few interventions for adolescents with poorly controlled T1D have 
been able to achieve significant change in glycemic control, and the majority of adolescents 
continue to fall short of ADA recommendations for HbA1c. It is possible that existing 
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interventions have not adequately addressed all of the layers of influence that impact T1D 
outcomes. Research has established connections between parental mental health, unsupportive 
parenting, parental distress, and poor adherence behaviors and worsening HbA1c (Eilander et al., 
2017; Hauser et al., 1990; Lewin et al., 2006). While several RCTs have tested interventions 
targeting the multiple systems that drive poor HbA1c (Ellis et al., 2004; Hackworth et al., 2013; 
Nansel et al., 2012; Wysocki et al., 2006), none have specifically targeted parental distress, and 
many have been limited in reach due to high costs and time requirements. Conceptualizing non-
adherence as a self-destructive behavior that is similar to substance use and delinquency opens the 
door for adaptations to MDFT for use with non-adherent T1D adolescents. The key features and 
structure of MDFT appear to fit well with the needs of adolescents with poorly controlled T1D. 
 MDFT can be adapted to target the factors interfering with adolescent T1D 
management including DD and diabetes-related family conflict. To increase feasibility, sessions 
will be completed during routine diabetes management appointments (occurring every 4 months) 
over a 24-month period, eight sessions in total. Despite this deviation from the original MDFT 
structure, other interventions designed for this population have shown significant results utilizing 
“low-intensity” interventions that last for similar durations (Anderson et al., 1999; Nansel et al., 
2012). Additional modifications include: (1) The utilization of two therapists, one working directly 
with the parent and one working directly with the adolescent. This will create more time for 
individual work with a therapist while reducing duration of appointments; (2) All in-person 
sessions include individual and work with the parent-child dyad. A co-therapy format will be 
utilized for work with the parent-child dyad; and (3) Stage 1 of the intervention will include 




Proposed Research Study 
PURPOSE AND RATIONALE 
Despite advances in diabetes glucose monitoring, intensive insulin management 
techniques, and interventions addressing barriers to diabetes management, most adolescents with 
T1D do not meet recommended standards for glycemic control (Mayer-Davis et al., 2017; Wood 
et al., 2013). Barriers to achieving glycemic control exist at the individual and familial level. An 
increased desire for independence during adolescence combined with hormonal and physiological 
changes, make diabetes-related family conflict and distress more likely and glycemic control more 
difficult to achieve. The DCCT showed that intensive diabetes management regimens and the 
maintenance of adequate glycemic control can reduce the progression of microvascular and 
neuropathic complications by 27-76% in patients over the age of 13 years (DCCT Research Group, 
1994). Poor glycemic control and resulting medical complications can exacerbate conflict in the 
home, cause diabetes related distress, and patient/ family “burn-out” (Amiel, Sherwin, Simonson, 
Lauritano, & Tamborlane, 1986). This creates a destructive cycle that makes optimal glycemic 
control even more difficult to achieve.  
Educational, behavioral, and psychological interventions to date have produced small to 
moderate effects on HbA1c (Hood et al., 2010; Law et al., 2014; Savage et al., 2010). Despite 
known associations between adherence, DD, diabetes-related family conflict, and glycemic control 
(Anderson et al., 2002; Lewin et al., 2006), most interventions have not targeted these psycho-
social variables. Furthermore, while many interventions measure parental distress few have 
specifically targeted parental distress as part of intervention (Eccleston et al., 2015; Hilliard et al., 
2016). It has been suggested that multicomponent interventions that target the social, emotional, 
and family processes that facilitate diabetes management have the potential to be more effective 
(Ellis et al., 2005; Hood et al., 2010; Wysocki et al., 2006).  
The current study evaluates the effectiveness of MDFT-T1D that is a multidimensional 
approach based on the hypothesis that reductions in target symptoms and increases in adaptive 
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behaviors occur via multiple pathways, in differing contexts, and through different mechanisms 
(Cynthia L. Rowe et al., 2016). The adapted MDFT-T1D intervention will target at-risk 
adolescents aged 12-16 years, who are identified as having chronically poor glycemic control, and 
the parent or caregiver most involved in their daily diabetes care. The two-year (24 month) 
intervention will take place at regular diabetes management appointments (eight in person sessions 
total) and target HbA1c, diabetes management tasks (blood glucose monitoring frequency), DD 
(parent and child distress targeted individually and together), and diabetes-related family conflict. 
Follow-up assessments will take place 6-months after the final in-person session.  Primary 
outcomes will include measures of HbA1c, BGMF, and adolescent DD; parent DD; and parent-
adolescent reported diabetes related conflict. 
RESEARCH QUESTIONS AND HYPOTHESES 
The following research questions will guide the evaluation of MDFT-T1D. Primary 
outcomes include measures of adolescent HbA1c, BGMF, and adolescent diabetes distress; parent 
reported diabetes distress; and parent and adolescent reported diabetes related conflict. 
Research Question 1:  
Relative to families receiving SC, to what extent does MDFT-T1D impact the glycemic control of 
adolescents with poorly controlled T1D? 
Hypothesis 1.1 
There will be a significant effect of time on HbA1c that depends on treatment assignment. 
More specifically, compared to adolescents randomized to the SC group, adolescents who 
receive MDFT-T1D will demonstrate significantly lower HbA1c levels at post-intervention 




Adolescents randomized to receive MDFT-T1D will demonstrate significantly lower HbA1c 
levels from baseline to post-intervention and from baseline to the 6-month follow-up. 
Rationale: 
Adolescents with T1D consistently display poor glycemic control as measured by HbA1c 
(Luyckx & Seiffge-Krenke, 2009; Mayer-Davis et al., 2017) and have HbA1c levels 
significantly above ADA recommendations (Miller et al., 2015). It is important to consider 
multiple factors that could interfere with adolescents’ ability to control their HbA1c. Given 
the complex interactions between family functioning, diabetes related distress, adherence 
to treatment and glycemic control it is unlikely for interventions with a singular focus to 
significantly impact HbA1c (Borus & Laffel, 2010; Chew et al., 2014; Datye et al., 2015; 
Hilliard et al., 2013). MDFT-T1D has been designed to simultaneously target parent and 
adolescent DD and family conflict, as well as diabetes management routines, 
communication, and problem-solving ability. Given that each target of MDFT-T1D 
uniquely contributes to glycemic control, it is expected that parent-adolescent dyads 
receiving the intervention will be more resilient to common barriers that interfere with 
glycemic control – and thus, more likely to demonstrate significantly improved HbA1c 
levels post-intervention. Additionally, other office-based interventions (Anderson et al., 
1999) of similar duration and intensity (i.e. number of session) have successfully reduced 
HbA1c levels in adolescents with T1D, with intervention effects increasing in magnitude 
over a follow-up period (Nansel et al., 2012).  
Research Question 2:  
Relative to families receiving standard care, to what extent does MDFT-T1D impact BGMF in 




There will be a significant effect of time on BGMF that depends on treatment assignment. 
Compared to adolescents randomized to the SC group, adolescents who receive MDFT-
T1D will demonstrate significantly greater frequency of BGM at post-intervention and at 
the six-month follow-up. 
Hypothesis 2.2 
Adolescents randomized to receive MDFT-T1D will show improvements in BGMF from 
baseline to post-intervention and from baseline to the six-month follow-up.  
Rationale: 
BGMF is a proxy behavior for adherence that has been linked to HbA1c, overall adherence, 
diabetes burnout, and distress (Datye et al., 2015; Helgeson, Honcharuk, Becker, Escobar, & 
Siminerio, 2011). Trajectory analyses in emerging adolescents with T1D show concurrent 
deterioration in glycemic control and adherence, as measured by BGMF (Helgeson et al., 2011; 
Hilliard et al., 2013). Evidence also supports a mediating role of negative family functioning on 
BGMF and glycemic control (Lewin et al., 2006). The MDFT-T1D intervention will target 
negative family interactions and work to increase the psychological well-being of the adolescent 
with T1D and their caregiver. Thus, it is expected that participants in the MDFT-T1D group will 
demonstrate increased BGMF.      
Research Question 3 
Relative to families receiving standard care, to what extent does MDFT-T1D impact self-reported 
diabetes-related conflict in the families of adolescents with poorly controlled T1D? 
Hypothesis 3.1 
There will be a significant effect of time on diabetes-related family conflict that depends 
on treatment assignment. Compared to families randomized to receive SC, families 
 
 27 
receiving MDFT-T1D will report significantly lower measures of diabetes-related family 
conflict at post-intervention and at the 6-month follow-up. 
Hypothesis 3.2 
Families that receive MDFT-T1D will report reductions in diabetes-related family conflict 
from baseline to post-intervention and from baseline to the 6-month follow-up. 
Rationale 
Family functioning surrounding adolescent diabetes management has demonstrated robust 
associations with diabetes glycemic control (Miller-Johnson et al., 1994), adequate diabetes 
management (Lewin et al., 2006), and diabetes-related quality of life (QoL) (M. Grey, Boland, Yu, 
Sullivan-Bolyai, & Tamborlane, 1998). Families of adolescents with poorly controlled T1D 
experience heightened levels of diabetes-related family conflict (Williams et al., 2009) and that 
poor communication about disease management tasks which causes additional friction that further 
influences metabolic control (Anderson et al., 2002). By intervening at the parent-adolescent 
relationship level, the MDFT-T1D intervention will focus on improving family cohesion, family 
problem solving, and communication patterns. Thus, it is expected that the adolescents and parents 
receiving MDFT-T1D will show reductions in family conflict and improvements in BGMF. 
Research Question 4: 
Relative to families receiving SC, to what extent does MDFT-T1D impact DD reported by parents 
and by adolescents with poorly controlled T1D? 
Hypothesis 4.1 
There will be a significant effect of time on adolescent reported DD that depends on 
treatment assignment. Compared to adolescents randomized to the SC group, adolescents 





Adolescents receiving MDFT-T1D will report reductions in DD from baseline to post-
intervention and from baseline to the 6-month follow-up. 
Hypothesis 4.3 
There will be a significant effect of time on primary caregiver reported DD that depends 
on treatment assignment. Compared to parents randomized to the SC group, parents who 
receive MDFT-T1D will report significantly lower DD at post-intervention and at the 6-
month follow-up. 
Hypothesis 4.4 
Parents receiving MDFT-T1D will report reductions in DD from baseline to post-
intervention and from baseline to the 6-month follow-up. 
Rationale 
The impact of T1D extends beyond physical consequences and impacts psychological 
wellbeing of both the individual with T1D and their family. During adolescence changes in 
insulin sensitivity related to hormones and rapid growth, complicate insulin management 
(Dunger, 1992). The changes and unpredictable nature of T1D management during adolescence 
are thought to be the main contributors to parent and adolescent DD (Mullins et al., 2007). 
Adolescents and parents in the MDFT-T1D group will receive individualized psychological 
support to target DD. Thus, DD is expected to decline. Further, DD is associated with family 









Participants include 110 adolescents between the ages of 12 -16 years and the parent most 
involved in their diabetes care. All participating adolescents will be receiving T1D care at a 
multidisciplinary pediatric endocrinology clinic in the Central Texas area. Inclusion criteria 
include: (a) T1D diagnosis for at least one year; (b) Two or more consecutive HbA1c readings 
above 8% (indicator for poorly controlled T1D); (c) Agreement by at least one parent to 
participate; (d) Agreement by all involved participants to attend all routinely scheduled clinic 
appointments; (e) A working phone or alternative form of communication to be in touch with 
research staff; (f) Mastery of English and (g) Intent to continue receiving diabetes care at the 
enrolling center. Exclusion criteria include: (a) The adolescent does not live in the home with 
their primary caregiver; (b) A current diagnosis of Psychosis, Major Depression, Autism 
Spectrum Disorder, and adolescents or parent/primary caregiver with an IQ below 85.  
Measures 
Demographic Information 
Prior to study participation, families will be asked to complete a demographic form 
(Appendix D). 
Adolescent Outcome Measures 
Glycemic Control will be estimated by routine HbA1c assays, which provide an estimate 
of average blood glucose concentration over the previous three to four months. HbA1c levels are 
routinely collected and processed by certified clinical laboratories on site during all scheduled 
appointments. HbA1c is a powerful determinate of diabetes outcomes and is recommended as a 
standard of care for the testing and monitoring of diabetes (Chiang et al., 2014). 
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BGMF, an adherence behavior, is often used as a proxy for overall adherence due to its 
robust association with glycemic control. Results from studies on adherence measurement in 
chronic illness indicate that it is necessary to include at least two methods to assess adherence 
(Quittner, Modi, Lemanek, Ievers-Landis, & Rapoff, 2008). Therefore, BGMF data will be 
collected in addition to HbA1c at every scheduled clinic visit. Due to high rates of misreporting 
in blood glucose logbooks and in self-report among T1D patients (Blackwell & Wheeler, 2016), 
BGMF data will be downloaded from adolescent’s blood glucose meters at scheduled 
appointments. Recent studies have preferred this method of monitoring over alternatives 
(Marker, Noser, Clements, & Patton, 2017). 
The Updated and revised- Diabetes Family Conflict Scale (DFCS) will assess diabetes 
specific conflict within the family. The youth self-report version was designed to assess 
adolescent reported diabetes-specific family conflict. The updated and revised DFCS includes 
new language about T1D management and technology, with additional changes that reflect post 
DCCT approaches to management (Hood et al., 2007). The 19-items on the DFCS-Youth Report 
assess conflict related to direct and indirect managing tasks. All items are answered on a 3-point 
scale (1=almost never argue, 2=sometimes argue, 3=almost always argue) with overall scores 
ranging from 19-57 (Appendix E). Rates of internal consistency for the DFCS youth report have 
been found to be acceptable at the total score level (α = 0.85) and the subscale level (Hood et al., 
2007; Song, Deatrick, Feetham, & Levin, 2013).  
The Problem Areas in Diabetes Teen Version (PAID-T) will be used to measure DD. The 
PAID-T was adapted from an adult version (Polonsky et al., 1995) and includes 26-items that 
assess emotional burden, family and friend distress, and regimen-specific distress (Shapiro et al., 
2018). Items are rated on a 6-point scale: 1-2, not a problem; 3-4, a moderate problem; 5-6, a 
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serious problem (Appendix F). Scores on the PAID-T are calculated by summing the item 
responses, with higher scores indicating greater distress. Scores on the PAID-T are positively 
correlated with depression symptoms and cut-point analyses demonstrated that scores above 90 
indicate presence of clinically significant distress (Hagger et al., 2017). The measure has strong 
internal consistency at the total score level (α = 0.96) and is highly correlated with commonly 
used measures of depression and distress (Weissberg‐Benchell & Antisdel‐Lomaglio, 2011). 
Parent Outcome Measures 
The Updated and revised- Diabetes Family Conflict Scale (DFCS) – Caregiver Report 
(Appendix E) will assess participating parents’ report of diabetes-specific family conflict. To 
provide consistency across the caregiver and teen versions, the updated and revised DFCS for 
caregivers includes the same 19-items used on the teen version and the same 3-point scale 
(1=almost never (argue), 2=sometimes, 3=almost always) (Hood et al., 2007). Rates of internal 
consistency for the DFCS caregiver report have been found to be acceptable at the total score 
level (α = 0.81) and at the subscale level (Song et al., 2013). Caregiver-reported conflict has been 
found to be correlated with the report of their own negative affect around blood glucose 
monitoring, a specific adherence behavior, and greater perceived caregiver burden (Song et al., 
2013). 
The Problem Areas in Diabetes – Parent Version (PAID-PR) (Appendix F) will assess 
perceived parental burden and distress associated with caring for a teen with diabetes. Parents 
will be asked to rate their level of agreement with 18 statements that assess two dimensions: 
daily burdens (concrete burdens) and worries about the future (unpredictable burdens). The 
PAID-PR has acceptable internal consistency at the total score level (α = 0.87) and at the 
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subscale levels. Test-retest for the PAID-PR was also found to be acceptable (Markowitz et al., 
2012). PAID-PR scores will be combined with PAID-T scores in outcome analyses.  
PROCEDURES 
Recruitment and Randomization 
All research activities will be approved by the University of Texas IRB prior to initiation 
of study recruitment. Participating pediatric endocrinology clinics will also sign site agreement 
paperwork (Appendix G) permitting study recruitment and all on-site study activity. The 
research team will identify eligible adolescents diagnosed with T1D for at least 1 year with two 
consecutive HbA1c readings above 8%, via medical chart review. All efforts will be made to 
recruit a diverse sample of families, consistent with the general population. 
Eligible families will be approached by RAs at scheduled clinic visits. Interested families 
will be asked to provide written parental and adolescent consent and complete demographic 
questionnaires. Eligibility criteria will be double checked prior to the randomization process. To 
ensure equivalence across treatment conditions, and to account for potential differences in 
outcome variables among participants, randomization will be stratified by age and HbA1c level 
obtained at the baseline visit. Research staff will meet with families after their scheduled 
appointment to inform them of their randomization group and explain how the study will 
proceed. Participants will be assigned an ID number to help secure confidentiality.  
Data Collection 
ADA recommends quarterly diabetes management follow-up appointments for youth 
with T1D, so collecting measures at these appointments will not present any additional burden 
on participating families. Collection of all measures (HbA1c, BGMF, PAID-T, PAID-PR, 
DFCS) will occur at roughly 3-month intervals during regularly scheduled appointments 
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(Markowitz, Volkening, & Laffel, 2014). All Data will be stored on Redcap, a secure web-based 
application designed to support data capture for research studies (Harris et al., 2009). The 
database for RedCap is hosted at the Population Research Center, which will be used as a central 
location for data processing and management. HbA1c and BGMF are already routinely collected 
during scheduled appointments as part of standard care, so RAs will collect this data from 
medical records and upload values into RedCap. Participants will be provided with a tablet to 
complete PAID-T, PAID-PR, and DFCS using a unique survey link attached to an assigned 
participant ID. A no-skip algorithm will prevent participants from skipping questions. Notes 
from remote check-ins will be secured in the notes section also connected to participant’s 
individual RedCap IDs. Within a week of their 24-month appointment, post intervention self-
report measures will be completed following the same procedures noted above. Finally, six-
months after participants complete the post-assessments, follow-up data will be collected using 
the same procedures noted above. Figure 1 (Appendix A) describes the study process. 
Treatment and Control 
Standard Care (SC) Group 
Participants in the SC condition will receive diabetes care consistent with prevailing 
clinical practice. All multidisciplinary pediatric endocrinology clinics in the Central 
Texas area follow the ADA guidelines. Treating physicians create glycemic targets for 
each adolescent and collect and process measures of HbA1c during quarterly visits. All 
patients are also asked to check their blood glucose level three or more times daily and 
bring their monitors to all scheduled appointments. At quarterly appointments (once 
every three months), all patients will meet with a pediatric endocrinologist (or other 
qualified clinician) and on an as-needed basis they will meet with a nutritionist and/or a 
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diabetes educator. Ongoing nutrition support and diabetes education are part of standard 
care and are provided only when needed. Quarterly visits are typically scheduled for two 
hours but tend to range between 30-90 minutes. Given the especially high rates of missed 
medical appointments among adolescents with poor glycemic control (Markowitz et al., 
2014), research-affiliated care ambassadors will send text message reminders to 
adolescents and parents 1-week prior to their scheduled appointments. 
MDFT-T1D Group 
In addition to the standard care, families receiving MDFT-T1D will have eight in person 
sessions and 50+ check-in phone calls (between sessions) by highly trained psychologists 
or doctoral students over the 24-month intervention period. Parent and Child therapists 
will be clinical psychologists and/or doctoral students who have experience working in 
chronic illness populations and extensive training in the challenges specific to youth with 
diabetes. All therapists will be trained in general MDFT principles and the adapted 
program. Therapists will receive weekly supervision by a licensed psychologist trained in 
MDFT throughout the study. A brief description of the phases of treatment and session 
structure, targets and goals of sessions (Appendix A), and between-session calls 
(Appendix C) will be summarized.  
Session Structure 
Parent-adolescent dyad randomized to MDFT-T1D will be assigned a therapist for the 
parent and for the adolescent who will work with them throughout the 24-months of active 
treatment. The first session will be scheduled for 60-90 minutes (future sessions will be 60 
minutes) and will occur within a week of study enrollment. Before starting each session, the 
adolescent and parent will be provided with an encrypted tablet to complete the required self-
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report measures, which is expected to take about 10 minutes. Sessions will follow the same 
structure: first the parent and adolescent will meet individually with assigned therapists (20-30 
minutes) and then will meet together with both therapists’ present (20-30 minutes). Therapists 
may choose to engage additional individuals who impact diabetes management, which may 
include other family members, peers, or teachers. 
Between the first and second session, both the adolescent and parent will receive weekly 
phone calls lasting 30- to 60-minutes. Calls after sessions two, three, four, five, six, and seven 
will occur on a bi-weekly basis for the same duration. Calls will be scheduled at times that are 
convenient for the adolescent and parent and all calls will include brief check-ins about: (1) 
Blood glucose monitoring, (2) Distress that may or may not be related to their (or their child’s) 
diabetes, and (3) Diabetes-related family conflict. Therapists will use calls to gather presenting 
problems at the individual and familial level, continue to establish rapport, and (in later sessions) 
extend topics discussed during in-person sessions.  
Phase 1: Building a Foundation for Change 
The three sessions that comprise the first phase of treatment focus on creating an 
environment where parent and adolescent feel respected and understood. Phase one treatment 
goals include developing strong therapeutic relationships with the parent-adolescent dyad, 
learning about the issues with T1D management from the perspective of both parent and 
adolescent, and enhancing parent and adolescent motivation and participation. During the 
individual meeting, parent and adolescent sessions will focus on: (1) Rapport building, (2) 
Normalizing Experiences with T1D and expanding T1D related knowledge, (3) Assessment of 
perceived barriers to T1D care, adherence challenges, conflict, and DD. During family meeting 
time, phase one sessions include: (1) The “What’s in it for you” technique (Liddle, 2016), which 
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is used to help create a comfortable environment for the dyad to grow from, (2) Introduction and 
practice of family problem solving and (3) Processing of a simulated living with T1D 
experience. Phone contacts between session one and two will occur weekly and focus on 
building the therapeutic alliance and gathering information about patterns of behaviors and 
potential areas for growth. All future contacts between sessions will build on session content and 
occur on a bi-weekly basis. 
A “living with diabetes simulation” is introduced to families at the end of session two. 
Therapists explain the week-long parent simulation of T1D, briefly train parents in T1D 
management regimens/insulin measurement and explain what the week will involve. A handout 
detailing the simulation experience and agreed upon start date is provided. Living with diabetes 
simulation has been used in other family-focused diabetes interventions and found to be a highly 
efficacious treatment component (Satin et al., 1989).  
Bi-weekly calls after session two include a check-in about T1D management tasks, 
barriers to adherence, burnout and DD, and family conflict. Therapists refer to the problem-
solving framework to help the parent and/or adolescent problem-solve for issues brought up on 
phone calls. The bi-weekly parent call that occurs two weeks before an in-person session will be 
dedicated to preparing the parent for a living with diabetes simulation. The week-long simulation 
(occurring a week before session three) requires parents to perform daily blood glucose checks 
on the child’s insulin schedule, administer multiple daily injections of sterile saline, and regulate 
carbohydrate intake. At a random time during this week, parents are notified by their therapist of 
the onset of “hypoglycemia” and must manage one simulated hypoglycemic event.  
Session three is a combined session that largely focuses on processing living with 
diabetes simulation experience. For families that do not engage in the simulation, therapists will 
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engage parent-adolescent dyad in conversation about potential barriers. Therapists work with on-
site diabetes educators to develop an educational pamphlet on diabetes distress and burnout, 
which may be particularly relevant during this session. The adolescent and parent will share what 
distress feels and looks like for them personally and brainstorm ideas for how they can cope 
individually and together. Therapists explain how to self-monitor for distress. The group 
practices with an example from the family or use a hypothetical example common among 
diabetes families.  
Phase 2: Facilitate Individual and Family Change 
Sessions four through seven, are delivered in an order that makes sense for parent-
adolescent dyad. Using challenges and goals discussed during phase one, therapists can tailor the 
order of phase two sessions to address most prevalent themes that are causing problems in the lives 
of the adolescent and parent. Bi-weekly phone calls after each phase two session extend in-session 
therapeutic intervention and help families apply new strategies to issues that arise in their lives. 
Phase two sessions target diabetes-related distress, diabetes-related family conflict, and barriers to 
adherence using a combination of individual therapy techniques and family-focused intervention. 
Session themes and trainings were selected due to their known positive impact in similar 
populations. During individual meeting time, phase two sessions focus on: (1) Problem Solving 
for Individual-Level Barriers; (2) Individual Coping Skills Training; (3) Communicating Needs; 
and (4) Miscarried Helping. During family meeting time, phase 2 sessions will focus on: (1) Family 
Problem Solving Training and Practice; (2) Conflict Resolution Training; (3) Family 
Communication Training; and (4) Perspective Taking.   
Phase 3: Solidify Change 
The final phase of treatment is focused on strengthening the accomplishments that have 
been achieved at the individual and family level. Therapists reinforce positive adherence 
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behaviors, attitudes, and skills learned, review progress, and assist parent-adolescent dyads in 
making new goals for the future. Session eight includes 20 minutes of individual session time 
focused on celebrating individual level progress; and 20-30 minutes of combined session time 
focused on creating goals for the future. Therapists may also assist the family in formalizing a 
plan to make healthier choices in the “heat of the moment”. Session eight is the last point of 
contact between the therapists and family. 
Table 2: MDFT-T1D Session Outline 







to engage in 
treatment 
Build therapeutic 
relationship, get to 
know the adolescent 
- Identify individual adherence barriers & difficulties 
- Discuss conflict & distress in the family 
- May utilize diabetes self-management profile 





Motivate parent to 
engage in treatment 
Build therapeutic 
relationship, get to 
know the parent 
- Identify personal struggles & distress about T1D 
management 
- Discuss conflict & distress in the family 





there is something in 
this for both of them 
Explain structure of 
therapy & assess 
motivation   
- - Rapport building as a group to enhance motivation 
- - identify barriers at the family level & start to 
establish individual- & family-level goals 
--- Weekly phone calls for parent and adolescent --- 
Calls focus on information gathering, psychoeducation for gaps in T1D knowledge, and resource sharing 










about T1D & discuss 
challenges of managing 
T1D 
- identify personal (& interpersonal) barriers  
- Evaluate awareness of T1D complications resulting 
from non-adherence & make the risk real by sharing 





Barriers to managing 
T1D & imperfection 
as a barrier to 
glycemic control 
Extend T1D knowledge 
& discuss challenges 
managing T1D w/ teens  
- Discuss perfectionistic beliefs as a possible barrier to 
adherence, a source of distress, & a source of conflict  





problem solving  
choose a barrier or area 
of conflict to problem 
solve for & introduce 
parent T1D simulation   
- Briefly Introduce Family problem solving 
- Introduce simulated diabetes project that will occur 
before next session & provide handout 
--- Bi-Weekly phone calls for parent and adolescent--- 






Process Living with 
T1D simulation  
Focus conversation on 
diabetes burnout & DD 
- Discuss DD & how to recognize when feeling it 
- Brainstorm how the dyad can support each other & 






Table 2 (Continued): MDFT-T1D Session Outline 








distress & conflict 
Problem-solving at the 
individual level & 
discuss challenges 
related to T1D 
- Apply problem-solving framework to personal 
struggles 
- Discuss family level challenges that could benefit from 






distress & conflict 
Problem-solving at the 
individual level & 
discuss challenges 
related to T1D 
- Apply problem-solving framework to personal 
struggles 
- Discuss family level challenges that could benefit from 
group problem solving  
Combined 
Meeting 
Discuss family problem 
solving & how to use 
the strategy 
Problem-solving 
activity w/ personal 
issue or common issue 
in T1D families 
- Help family use problem-solving for diabetes related 
family problem area 
- Model appropriate language & praise idea development  
--- Bi-Weekly phone calls for parent and adolescent--- 









distress & conflict 
Individual coping skills 
& teach CBT triangle 
- Explore different methods of coping   







distress & conflict 
Individual coping 
skills; teach CBT 
triangle 
- Explore different methods of coping   






Discuss how parent & 
adolescent can support 
each other & use of 
coping skills 
- Facilitate the making of an agreement between parent 
& adolescent to use coping skills when feeling distressed 
--- Bi-Weekly phone calls for parent and adolescent--- 








distress & conflict 
preferred 
communication styles 
- Discuss the skills needed to communicate one’s needs 
& role play with practice scenarios. (communicating 






distress & conflict 
preferred 
communication styles 
and psychoeducation on 
effective praise  
- Discuss gap between how parent communicates & how 
they would like to communicate their needs w/ the 
adolescent or other family members and practice 










- Discuss family communication, barriers to effective 
communication, & how to circumvent these barriers 
- Facilitate conversation about what is expected from each 
other in dialogue & how that impacts behavior 
- Create “family plan” to address ineffective communication 
--- Bi-Weekly phone calls for parent and adolescent--- 









distress & conflict 
Perspective Taking & 
acting vs. reacting  
- Target emotion regulation by taking perspectives of 
others  






distress & conflict 
Perspective Taking & 
acting vs. reacting 
- Review developmental changes during adolescence 
- Teach parenting skills & tools for appropriate 
monitoring; Cognitive restructuring may be helpful.  
Combined 
Meeting 
Introduce and discuss 
miscarried helping  
Reverse role play 
(parent as adolescent & 
adolescent as parent) 
- Help conduct and manage reverse role play  
- Help the parent and adolescent process this experience  
--- Bi-Weekly phone calls for parent and adolescent--- 
Calls focus on emotion regulation, family conflict, and unhelpful thought patterns. 
(Note: Ordering of phase 2 sessions is flexible) 
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Table 2 (Continued): MDFT-T1D Session Outline 








related distress & 
conflict 
Review individual progress 
& progress in family 
relationship  
- Provide space for reflection  







related distress & 
conflict 
Review individual progress 
& progress in family 
relationship  
- Provide space for reflection  






progress made  
Formalize family plan to 
help the dyad make 
healthy choices in “the 
heat of the moment” 
- Focus on strengthening family connection 
- Provide space for reflection  





Analyses and Expected Results 
Experimental Design 
This study will utilize a repeated measures design. Regardless of treatment condition, 
families will be enrolled in the study for two and a half years (30-months) and data collection 
will occur at eight timepoints, each three-months apart. Measures collected at baseline, post 
intervention, and 6-month follow-up will be analyzed.  
A Priori Power Analysis 
A priori power analysis for RM ANOVA was conducted using G*Power software to 
determine the number of participants needed to detect a significant effect (Faul, Erdfelder, 
Buchner, & Lang, 2009). While the analyses will use RM ANCOVA, a RM ANOVA design for 
power calculations provides a more conservative estimate for the total number of participants 
needed. Previous RCTs of psychological interventions in child and adolescent T1D patients have 
found average treatment effects ranging from 0.33 to 0.46 (Hampson et al., 2000; Winkley et al., 
2006). To be conservative, power analyses were run with an effect size that fell between this 
range, r = 0.395 or f = .430, and an alpha level of 0.01 was chosen to correct for multiple 
comparisons. Since several of the outcome measures are correlated, baseline data outcomes will 
be used as covariates. Outside of treatment, HbA1c scores tend to be highly consistent year-to-
year, however test-retest information is not typically measured (Pinhas-Hamiel et al., 2014). The 
test-retest reliability for the DFCS is .62, lower than what would be expected for the reliability of 
HbA1c. Using this value in power analyses will yield a larger sample size estimate and will 
increase the likelihood of achieving an appropriate level of power. To detect the significance of a 
moderate effect size with a power of 0.80 at an alpha of 0.01 with two groups (MDFT-T1D vs. 
SC), 3 timepoints of measure (Baseline, Post, and 6-month follow-up) and the correlation among 
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repeated measures set at r = 0.62, 90 participants (45 per group) will be needed for analyses. To 
account for expected attrition, researchers will recruit an additional 20 participants, for a total of 
110 participants, 55 per group. 
Analysis Approach 
RM ANCOVA will be used to examine the between-subject effect across treatment and 
within-subject change over time for each outcome measure. To reduce statistical comparisons 
and control for type one error, parent and adolescent DFCS scores will be combined to form a 
family conflict composite score. Previous studies have found high correlations between parent 
and adolescent conflict, making it reasonable to combine them into a single composite (Wysocki 
et al., 2007). Parent and adolescent DFCS scores will also be explored separately to ensure that 
outcomes do not differ significantly from combined outcomes. Similarity of baseline 
characteristics of participants in the MDFT-T1D group and the SC group will be assessed using 
t-tests and additional appropriate summary statistics.  
While randomization procedures are expected to eliminate major imbalances in baseline 
characteristics across experimental groups, remaining imbalances will be explored. Previous 
research shows that older age, longer diabetes duration, ethnic minority status, unmarried 
caregiver status, greater distress, and diabetes-specific family conflict each predict a trajectory of 
poorer diabetes management and control (Hilliard et al., 2013); considerable overlap has also 
been found among the selected outcome variables. Unless these differences and overlap among 
variables are explored and potentially controlled for, outcomes could be impacted. In line with 
previous investigations in youth with T1D; all baseline outcome measures and any imbalanced 
demographic variables will be used as covariates. Follow-up comparisons will determine the 
sources of any obtained significant main effects. Effect sizes will be estimated using Cohens d.  
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Preliminary Analyses  
Descriptive statistics including means and standard deviations will be reported for all 
outcome variables. Simple Pearson correlations will be calculated and described. Assumptions of 
linearity, normality, and variance will be tested by analyzing scatterplots and descriptive 
statistics, Q-Q plots, and histograms of standardized residuals, and inspecting results from 
Levene’s test to compare variation across groups. To test equality of regression slopes, group by 
covariate interactions will be tested to ensure that no significant variance is contributed by the 
interaction. If the increase in variance is significant when testing this assumption, ATI analyses 
will be conducted. Sphericity requires that variances of the differences for all pairs of repeated 
measures are equal. While SPSS does offer Mauchly’s test of sphericity, it has been shown to be 
unreliable, so it will be assumed that this assumption is violated. The Greenhouse-Geisser 
Epsilon and Huynh-Feldt Epsilon values provided in Mauchley’s test of Sphericity can be used 
to make adjustment for the within-subjects effects. If the Greenhouse-Geisser Epsilon is <0.7, the 
Greenhouse-Geisser adjustment will be used to determine within-subjects effect; If the 
Greenhouse-Geisser Epsilon is >0.7, the Huynh-Feldt adjustment will be used to determine 
within-subjects effect. Bonferroni adjustments will be used to account for the three levels of the 
within-subjects variable. Pairwise comparisons (t-tests) will explore within-group changes across 
the three timepoints. 
Expected Results 
After assessing assumptions of ANCOVA, separate analyses will be conducted for each 
primary outcome measure. To deal with the assumed violation of sphericity either the 
Greenhouse-Geisser or Huynh-Feldt adjustment will be used to interpret outcomes for within-
subject effects of time and the interaction between time and treatment. Analyses for each 
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outcome variable will assess for (a) an interaction between treatment and time and (b) within-
group change between time points. The between group variable for ANCOVA analyses will be 
treatment assignment (MDFT-T1D vs. SC) and the within group variable will be time (baseline, 
post, follow-up).  
Research Question 1: Glycemic Control 
Time by Treatment Interaction: Hypothesis 1.1. To evaluate the effect of treatment on 
HbA1c, analyses will first look at the main effect of time on HbA1c, followed by exploration of 
the interaction between time and treatment. The first analysis (main effect of time) will look at 
whether the average HbA1c (average across participants in both groups) significantly changed 
over time. The interaction analysis will consider whether mean HbA1c at each time point 
(baseline, post-intervention, and follow-up) differed depending on treatment group assignment 
(MDFT-T1D vs. SC). After controlling for covariates, it is expected that time by treatment 
interaction will be significant and show a decrease in average HbA1c percentage over time for 
participants the MDFT-T1D group but not for participants in the SC group. Follow-up t-tests at 
each timepoint are expected to show significant differences in HbA1c across groups, where 
HbA1c percentages in the MDFT-T1D group are significantly lower than those in the SC group 
at post-intervention and at the 6-month follow-up. 
Follow-up Tests: Hypothesis 1.2. The second hypothesis predicts the direction of change 
within the MDFT-T1D group from baseline to post intervention assessment and from baseline to 
follow-up assessment. For those receiving MDFT-T1D, it is expected that pairwise comparisons 
among timepoints will show significant decreases (improvements) in HbA1c percentages from 
baseline to post-intervention and from baseline to 6-month intervention. It is expected that 
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significant declines in HbA1c percentage will be seen at post-intervention and maintained over 
the 6-month follow-up period. 
Research Question 2: Blood Glucose Monitoring Frequency 
Time by Treatment Interaction: Hypothesis 2.1. To evaluate the effect of treatment on 
BGMF, analyses will first look at the main effect of time on BGMF, followed by exploration of 
the interaction between time and treatment. The first analysis (main effect of time) will look at 
whether the average BGMF (average across participants in both groups) significantly changed 
over time. The interaction analysis will consider whether the mean BGMF at each time point 
(baseline, post-intervention, and follow-up) differed depending on treatment group assignment 
(MDFT-T1D vs. SC). After controlling for covariates, it is expected that time by treatment 
interaction will be significant and show an increase in average BGMF over time for participants 
the MDFT-T1D group but not for participants in the SC group. Follow-up t-tests at each 
timepoint are expected to show significant differences in BGMF across groups, where BGMF for 
those in the MDFT-T1D group are significantly higher than those in the SC group at post-
intervention and at the 6-month follow-up. 
Follow-up Test: Hypotheses 2.2. The second hypothesis predicts the direction of change 
within the MDFT-T1D group from baseline to post intervention assessment and from baseline to 
follow-up assessment. For those receiving MDFT-T1D, it is expected that pairwise comparisons 
among timepoints will show significant increases BGMF from baseline to post-intervention and 
from baseline to 6-month intervention. It is expected that significant increases in BGMF 
percentage will be seen at post-intervention and maintained over the 6-month follow-up period. 
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Research Question 3: Family Conflict 
Between-Group Differences: Hypothesis 3.1. To evaluate the effect of treatment on 
family-reported conflict, analyses will first look at the main effect of time on family conflict, 
followed by exploration of the interaction between time and treatment. The first analysis (main 
effect of time) will look at whether average conflict scores (average across families from both 
groups) significantly changed over time. The interaction analysis will consider whether mean 
conflict scores at each time point (baseline, post-intervention, and follow-up) differed depending 
on treatment group assignment (MDFT-T1D vs. SC). After controlling for covariates, it is 
expected that the time by treatment interaction will be significant and show a decrease in average 
family conflict scores over time for families who receive MDFT-T1D but not those that receive 
SC. Follow-up t-tests at each timepoint are expected to show significant differences in family 
conflict across groups, where conflict scores from the MDFT-T1D families are significantly 
lower than those from the SC families at post-intervention and at the 6-month follow-up. 
Within-Group Differences: Hypotheses 3.2. The second hypothesis predicts the direction 
of change within the MDFT-T1D group from baseline to post intervention assessment and from 
baseline to follow-up assessment. For those in the MDFT-T1D group, it is expected that pairwise 
comparisons among timepoints will show significant decreases in family reported conflict scores 
from baseline to post-intervention and from baseline to 6-month intervention. It is expected that 
significant declines in family conflict will be seen at post-intervention and maintained over the 6-
month follow-up period. 
Research Question 4: Diabetes Distress 
Adolescent Between-Group Differences: Hypothesis 4.1. To evaluate the effect of 
treatment on adolescent-reported DD, analyses will first look at the main effect of time on PAID-
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T scores followed by exploration of the interaction between time and treatment. The first 
analysis (main effect of time) will look at whether average PAID-T scores (average across 
adolescents in both groups) significantly changed over time. The interaction analysis will 
consider whether mean PAID-T scores at each time point (baseline, post-intervention, and 
follow-up) differ depending on treatment assignment (MDFT-T1D vs. SC). After controlling for 
the covariates, it is expected that the time by treatment interaction will be significant and show a 
decrease in average PAID-T scores over time for adolescents in the MDFT-T1D group but not 
for adolescents in the SC group. Follow-up t-tests at each timepoint are expected to show 
significant differences in adolescent-reported DD across groups, where DD scores from the 
adolescents in the MDFT-T1D group are significantly lower than those from the adolescents in 
the SC group at post-intervention and at the 6-month follow-up. 
Adolescent Within -Group Differences: Hypotheses 4.2. The second hypothesis predicts 
the direction of change within the MDFT-T1D group from baseline to post intervention 
assessment and from baseline to follow-up assessment. For adolescents in the MDFT-T1D 
group, it is expected that pairwise comparisons among timepoints will show significant decreases 
in PAID-T scores from baseline to post-intervention and from baseline to 6-month intervention. 
It is expected that significant declines in adolescent reported DD will be seen at post-intervention 
and maintained over the 6-month follow-up period. 
Parent Between-Group Differences: Hypothesis 4.3. To evaluate the effect of treatment 
on parent-reported DD, analyses will first look at the main effect of time on PAID-PR scores, 
followed by exploration of the interaction between time and treatment. The first analysis (main 
effect of time) will look at whether the average PAID-PR scores (average across parents from 
both groups) significantly changed over time. The interaction analysis will consider whether the 
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mean PAID-PR scores at each time point (baseline, post-intervention, and follow-up) differed 
depending on treatment group assignment (MDFT-T1D vs. SC). After controlling for the 
covariates, it is expected that the time by treatment interaction will be significant and show a 
decrease in average PAID-PR scores over time for parents in the MDFT-T1D group but not for 
parents in the SC group. Follow-up t-tests at each timepoint are expected to show significant 
differences in parent-reported DD across groups, where distress scores from the parents in the 
MDFT-T1D group are significantly lower than those from parents in the SC group at post-
intervention and at the 6-month follow-up. 
Parent Within -Group Differences: Hypotheses 4.4. The fourth hypothesis predicts that 
the direction of change within the MDFT-T1D group from baseline to post intervention 
assessment and from baseline to follow-up assessment. For parents in the MDFT-T1D group, it 
is expected that pairwise comparisons among timepoints will show significant decreases in 
PAID-PR scores from baseline to post-intervention and from baseline to 6-month intervention. It 
is expected that significant declines in parent reported diabetes-related distress will be seen at 






This paper provides a comprehensive description of MDFT-T1D and a proposed RCT 
that will evaluate the effectiveness of MDFT-T1D with adolescents who have poorly controlled 
T1D. MDFT-T1D is unlike other interventions developed for families with a child who has T1D 
in that it targets an adolescent and their parent/caregiver individually and together as a dyad. 
MDFT-T1D was built from theory to target multiple risk factors associated with T1D control and 
was designed to be delivered as part of routine T1D care. The duration of MDFT-T1D, 24-
months, allows the therapeutic work to extend through a transition period where adolescents 
begin to take over T1D responsibilities from their parent(s) or caregiver(s). By targeting several 
modifiable risk factors for poor glycemic control, in both the adolescent and parent, it is 
expected that MDFT-T1D will improve T1D outcomes, decrease psychological distress in 
adolescents and their participating parent or caregiver, and decrease conflict in the parent-
adolescent dyad. If this RCT can show significant effects in families receiving MDFT-T1D at the 
end of treatment and at the 6-month follow-up it would demonstrate preliminary support for the 
efficacy of this newly developed intervention for adolescents with poorly controlled T1D and 
would demonstrate the utility of targeting parents when working with this population. 
Replication RCTs evaluating MDFT-T1D in additional clinics in different regions of the U.S. 
would provide additional support for integrating this intervention into routine T1D care. 
Limitations of Current Design  
Several limitations to this study should be mentioned. First, because the proposed study 
will be conducted over a 2-year period, there is a chance that families will be lost to due to 
moves or changes in care. Research shows that between 5-11% (2018 moving statistics) of 
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families move out of state each year.  A priori power analyses accounted for potential attrition in 
calculating the necessary sample size. Second, it is worth noting that all families participating in 
the intervention will be recruited while attending their routine T1D care visits. This indicates that 
families enrolled in this study will be at the least partially engaged in T1D care, which could 
limit the generalizability of study results. Families who are less engaged in T1D care, cannot 
access care, or who receive T1D care from their primary care physician may be of even greater 
need for these services. Additionally, given that all participants will be recruited from 
multidisciplinary clinics located in the same region of the U.S., there is a chance that there will 
be limited diversity in the sample. Existing research has shown that there are differences in 
coping related to income and race/ethnicity and there is an influence of coping on self-
management and health outcomes in adolescents with T1D (Compas, Jaser, Dunn, & Rodriguez, 
2012). While baseline demographic characteristics will be controlled for in analyses, a lack of 
diversity in the sample would still limit the generalizability of results and provide additional 
support for the continued study of MDFT-T1D in more diverse populations.   
Implications for Future Research 
If this study can show that MDFT-T1D significantly improves the physiological and 
psychological functioning of adolescents with T1D and involved family members, results would 
shed light on important considerations for clinical practice in routine T1D care. Additional 
analyses could examine data from scheduled appointments between baseline and the post-
intervention assessment to track change over time. Examination of individual change over time, 
group change over time, and the mechanisms of change for the treatment effects of interest may 
provide important information that could help reduce the duration of the intervention. Future 
studies should replicate MDFT-T1D with diverse populations across different regions of the U.S. 
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populations and continue to refine the intervention. Cost analyses of MDFT-T1D would provide 
valuable information regarding the feasibility of implementing MDFT-T1D on a larger scale.  
Recent research has found high average HbA1c levels in the first two years after onset of 
T1D might indicate higher risk for later psychiatric comorbidities (Sildorf et al., 2018). Since 
psychiatric comorbidity in youth with T1D increases risk for poor metabolic outcomes, some 
have suggested that focusing on the disease burden earlier might improve later outcomes. MDFT 
has already been successfully adapted as a prevention program for at-risk youth (Hogue et al., 
2002), so future studies could make similar adaptations to evaluate MDFT-T1D on youth who 







Appendix A: Ten Guiding Principles for MDFT  
Principle Description 
Adolescent problem behaviors are 
multidimensional phenomena 
Individual biological, social, cognitive, personality, 
interpersonal, familial, developmental, & social ecological 
aspects all contribute to the development, continuation, 
worsening, & chronicity of problems.  
Family functioning is instrumental 
in creating new, developmentally 
adaptive lifestyle alternatives for 
adolescents. 
Relationships with parents, siblings, & other family members 
are fundamental areas for assessment & change. Day-to-day 
family exchanges offer opportunities to re-track 
developmental functioning.  
Problem situations provide 
information and opportunity. 
Symptoms & problem situations provide assessment 
information as well as essential intervention opportunities.  
Change is multifaceted, 
multidetermined, and stage 
oriented. 
Behavioral change emerges from interaction among levels of 
systems, people, domains of functioning, & intrapersonal/ 
interpersonal processes.  
Motivation is malleable but is not 
assumed. 
Motivation will not always be present with adolescents or 
parents & treatment receptivity & motivation will vary 
across family members. Treatment reluctance is not normal; 
motivating clients about treatment participation & change is 
a fundamental therapeutic task.  
Multiple therapeutic alliances are 
required; they create a foundation 
for change. 
Therapists create individual working relationships with the 
adolescent, individual parent(s) or caregiver(s), & 
individuals outside of the family. 
Individualized interventions foster 
developmental competencies. 
Interventions have universal aspects but are tailored to match 
the family’s background, history, interactional style, culture, 
& experiences. Structure & flexibility are two sides of the 
same therapeutic coin.  
Treatment occurs in stages: 
continuity is stressed. 
Core operations, parts of sessions, whole sessions, stages of 
therapy, & therapy, is conceived & organized in stages. 
Linking pieces of therapeutic work across sessions is critical 
& creates change enabling circumstances.  
Therapist responsibility is 
emphasized. 
Therapists (1) promote participation and motivation, (2) 
create a workable agenda & clinical focus, (3) provide 
thematic focus & consistency, (4) prompt behavior change, 
(5) evaluate ongoing success of interventions, & (6) per this 
feedback, collaboratively, revise interventions as needed.  
Therapist attitude is fundamental 
to success. 
Therapists advocate for adolescents/parents & are optimistic 
about change. They are sensitivity to contextual or societal 
influence rather than reasons for how problems began or 
excuses for why change has not occurred. 
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Appendix B: Study procedure flow diagram 
  
Research Participation Consent 
By RA at routine T1D appointment 
Complete Baseline Measures  
Medical Chart Review  
For targeted recruitment of adolescents 
with 2 HbA1c readings > 8% 
Randomization 
Stratified by HbA1c & age 
 
MDFT-T1D group Standard Care group 
Intervention 
24-month program 
8 in-person sessions 
Bi-weekly remote sessions  
Wait-list Control 
Receive standard care for 
duration of the intervention 
24-month post assessments and 6-month follow-up assessments  
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Appendix C: Weekly and Bi-Weekly phone call structure 
Weekly Calls 
-after session one 
only- 
(30-60 min)  
Target Areas Description 
Building Rapport 
Parent: Check-in with parent about the week. Focus on 
building rapport  
Adolescent: Check-in with adolescent about the week. Focus 





Parent: Gather info (struggles, accomplishments, & any 
occurrences related to T1D) without active intervention 
Adolescent: Gather info (struggles, progress, & any 
occurrences related to T1D) without active intervention 
Adolescent 
Development 
Parent: Psychoeducation about adolescent development & 
normalizing changes that are recognized in their child  
Adolescent: Learn about their inner world; things at home, 
school, & internally. Normalize adolescent change 
Enhance 
Motivation 
Parent: provide opportunities for the parent to engage in 
reflection & self-examination; begin the change process 
Adolescent: provide opportunities for reflection & help them 
develop meaningful goals in all domains of life 
Bi-Weekly Calls 








Parent: Check-in about the 2-weeks. Problem solve & teach 
parental monitoring skills for problem areas  
Adolescent: Check-in about the 2-weeks. Use MI skills to 
reinforce positive management, be curious about new barriers 
& work to increase awareness. 
Personal 
Challenges & DD 
Parent: Discuss any challenges from the 2 weeks. Help 
parent problem solve or cope w/ challenging situations   
Adolescent: Discuss challenges from the 2 weeks. Help 
adolescent problem solve or cope  
Diabetes Related 
Conflict 
Parent: Check in about conflict related to T1D. Identify 
triggers, discuss alternative ways to respond, & encourage 
parent to mend conflict-related wounds  
Adolescent: Check in about conflict related to T1D. Identify 
triggers, discuss new ways to respond, & encourage them to 
mend any conflict-related wounds  
Skill Application  
Parent & Adolescent: Build on skills learned in previous 
session by making a goal for the next 2 weeks or engaging in 




Appendix D: Demographic Form 
1. CHILD AGE ______     PARENT AGE ______ 
2. CHILD GENDER _______    PARENT GENDER ________ 
o Prefer not to answer          Prefer not to answer 
 
3. CHILD RACE/ETHNICITY (select one)  
o White, not of Hispanic Origin 
o African American, not of Hispanic Origin  
o Hispanic/Latino 
o Asian American/Pacific Islander  
o Reported as Multi-Racial/Ethnic 
 
3.  PARENT RACE/ETHNICITY (select one) 
o White, not of Hispanic Origin 
o African American, not of Hispanic Origin  
o Hispanic/Latino 
o Asian American/Pacific Islander  
o Reported as Multi-Racial/Ethnic 
4. DURATION OF CHILD’S T1D ________ DATE OF T1D DIAGNOSIS __________ 
5. LAST HBA1C (%) _______  
6. FAMILY STRUCTURE  
o Two parents in the home 
o One parent in the home 
o Other: ________________ 
 
 
7. FAMILY INCOME (choose one) 
o Less than $50,000 
o $50,000 – $75,000  
o $75,000 – $100,000  
o $100,000 – $150,000  
o More than $150,000  
 
8. PARTICIPATING PARENT ________________ 
9. HIGHEST EDUCATIONAL LEVEL OF PARTICIPATING PARENT 
o Did not complete high school 
o High school diploma or G.E.D. 
o Some College 
o Associates Degree or Professional Training Degree 
o Bachelors degree (college) 
o Masters  
o Doctorate (for example PhD or PsyD) or Medical degree (MD or DO) 
 




Appendix E: Updated and revised-Diabetes Family Conflict Scale (DFCS) 
Updated and revised-Diabetes Family Conflict Scale (DFCS) – Adolescent Report Form  
Instructions: During the PAST MONTH, I have argued with my parent(s) about…. 
**The same items are used for the parent version, but parents are asked to indicate how much 




 Almost Never Sometimes Almost Always 
1. Remembering to give shots or to bolus (pump) 1 2 3 
2. Taking more or less insulin depending on results 1 2 3 
3. Remembering to check blood sugars 1 2 3 
4. Remembering clinic appointments 1 2 3 
5. Giving shots or boluses (pump) 1 2 3 
6. Meals and snacks 1 2 3 
7. Results of blood sugar monitoring 1 2 3 
8. The early signs of low blood sugar 1 2 3 
9. What to eat when away from home 1 2 3 
10. Making appointments with dentists and doctors 1 2 3 
11. Telling teachers about diabetes 1 2 3 
12. Telling friends about diabetes 1 2 3 
13. Carrying sugar/carbs for reactions 1 2 3 
14. School absences 1 2 3 
15. Supplies 1 2 3 
16. Telling relatives about diabetes 1 2 3 
17. Rotating injection sites or infusion sets (pump) 1 2 3 
18. Changes in health (like weight or infections) 1 2 3 
19. Logging blood sugar results 1 2 3 
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Appendix F: Problem Areas in Diabetes Questionnaire 
Problem Areas in Diabetes Questionnaire (PAID) – Teen Version 
Instructions: which of the following diabetes issues are currently a problem for you?  
Choose number that gives the best answer for you. Please provide an answer for each question. 
 
 Not a 
problem Moderate problem Serious problem 
1. Feeling sad when I think about having and living with 
diabetes. 1 2 3 4 5 6 
2. Not knowing if the mood or feelings I am having are related to 
my blood sugar levels. 1 2 3 4 5 6 
3. Feeling overwhelmed by my diabetes regimen. 1 2 3 4 5 6 
4. Feeling angry when I think about having and living with 
diabetes. 1 2 3 4 5 6 
5. Feeling constantly concerned about food and eating. 1 2 3 4 5 6 
6. Worrying about the future and the possibility of serious 
complications. 1 2 3 4 5 6 
7. Feeling upset when my diabetes management is “off-track”. 1 2 3 4 5 6 
8. Feeling “burned-out” by the constant effort to manage 
diabetes. 1 2 3 4 5 6 
9. Feeling that I am not checking my blood sugars often enough. 1 2 3 4 5 6 
10. Feeling unclear about exactly what or how much I should be 
doing to take care of my diabetes properly. 1 2 3 4 5 6 
11. Not feeling motivated to keep up with my daily diabetes 
tasks. 1 2 3 4 5 6 
12. Feeling discouraged or defeated when I see high blood sugar 
results on my meter. 1 2 3 4 5 6 
13. Feeling that my friends or family act like “diabetes police” 
(e.g. nag about eating properly, checking blood sugars, not 
trying hard enough). 
1 2 3 4 5 6 
14. Feeling like my parents don’t trust me to care for my 
diabetes. 1 2 3 4 5 6 
15. Feeling I must be perfect in my diabetes management. 1 2 3 4 5 6 
16. Missing or skipping blood sugar checks. 1 2 3 4 5 6 
17. Feeling that my blood sugars are often swinging wildly, no 
matter how hard I try. 1 2 3 4 5 6 
18. Feeling that I am often failing with my diabetes regimen. 1 2 3 4 5 6 
19. Feeling like my parents blame me for blood sugar numbers 
they don’t like. 1 2 3 4 5 6 
20. Feeling that my friends or family don’t understand how 
difficult living with diabetes can be. 1 2 3 4 5 6 
21. Feeling that I can’t control my eating. 1 2 3 4 5 6 
22. Worrying about my weight. 1 2 3 4 5 6 
23. Worrying that my diabetes gets in the way of having fun and 
being with my friends. 1 2 3 4 5 6 
24.Fitting my diabetes regimen into my day when I’m away from 
home (school, work, etc.). 1 2 3 4 5 6 
25. Worrying about getting low during sports activity. 1 2 3 4 5 6 
26. Feeling like my parents worry about complications too much. 1 2 3 4 5 6 
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Problem Areas in Diabetes Questionnaire (PAID) – Parent Report 
 
Instructions: which of the following diabetes-related issues are currently a problem for you?  
Choose number that gives the best answer for you. Please provide an answer for each question. 
 
  
 Not a problem Moderate problem Serious problem 
1. Not having clear and concrete goals for my child’s 
diabetes care. 1 2 3 4 5 6 
2. Feeling discouraged with my child’s diabetes treatment 
plan. 1 2 3 4 5 6 
3. Feeling scared when thinking about my child 
having/living with diabetes. 1 2 3 4 5 6 
4. Difficulty dealing with school staff. 1 2 3 4 5 6 
5. Feeling that my child is deprived regarding food and 
meals. 1 2 3 4 5 6 
6. Feeling that my child is excluded from activities/events 
because of his/her diabetes. 1 2 3 4 5 6 
7. Not knowing whether the mood or behavior my child is 
displaying is related to their blood sugar level.  1 2 3 4 5 6 
8. Feeling upset when my child’s blood sugars are out of 
range. 1 2 3 4 5 6 
9. Worrying about my child having a low blood sugar. 1 2 3 4 5 6 
10. Feeling angry when I think about my child 
having/living with diabetes. 1 2 3 4 5 6 
11. Feeling constantly concerned about what my child 
eats. 1 2 3 4 5 6 
12. Worrying about the future and the possibility of 
serious complications for my child.  1 2 3 4 5 6 
13. Feeling upset when my child’s diabetes management is 
“off track”. 1 2 3 4 5 6 
14. Worrying that my child will not be taken care of when 
away from home. 1 2 3 4 5 6 
15. Feeling like the “diabetes police” 1 2 3 4 5 6 
16. Feeling that diabetes takes up too much mental and 
physical energy.  1 2 3 4 5 6 
17. Feeling alone in managing my child’s diabetes.  1 2 3 4 5 6 
18. Worrying whether or not my child will remember to 
eat his/her snack. 1 2 3 4 5 6 
19. Feeling “burned out” by the constant effort to manage 
diabetes.  1 2 3 4 5 6 
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Appendix G: Site Agreement Paperwork 
 
x                                            x 
 
 
Dr. James Wilson, Ph.D. 
Chair, Institutional Review Board 
P.O. Box 7426    
Austin, TX 78713 
irbchair@austin.utexas.edu  
 
Dear Dr. Wilson: 
 
The purpose of this letter is to grant Jessica Tauber, a graduate student at the University of Texas 
at Austin, permission to conduct research at Dell Children’s Medical Center (DCMC).  The 
project, “Effects of adapted multi-dimensional family therapy on glycemic control, diabetes-
related family conflict and distress in the families of adolescents with poorly controlled type 1 
diabetes” entails the active recruitment and enrollment of 110 adolescents with type 1 diabetes 
(T1D) and a parent involved in their care into an intervention that will last 30-months. The 
intervention will target known risk factors for glycemic control and blood glucose monitoring 
frequency (parent/adolescent distress and diabetes-related family conflict) and will be delivered 
in 8-sessions at routinely scheduled diabetes care appointments. DCMC’s diabetes specialty 
clinic was selected because of the close ties with The University of Texas at Austin and the 
clinic’s desire to utilize a multidisciplinary care model. This research has the potential to 
improve glycemic control in adolescents who have poorly controlled T1D which would 
ultimately reduce the frequency of acute complications and medical costs- but also reduce the 
burden of T1D and improve patients’ health-related quality of life. At the conclusion of the 
study, results will be shared with DCMC. I, [insert directors name] do hereby grant permission 






Glossary of Terms 
BFST-D: Behavioral family systems therapy for diabetes 
BGL: Blood glucose levels  
BGMF: Blood glucose monitoring frequency  
CST: Coping skills training 
DCCT: Diabetes Control and Complications Trial 
DD: Diabetes distress 
DFCS: Diabetes family conflict scale  
DKA: Diabetic ketoacidosis  
EDIC: Epidemiology of Diabetes Interventions and Complications  
HbA1c: Glycosylated hemoglobin A1c 
MDFT: Multidimensional family therapy  
MDFT-T1D: Multidimensional family therapy for type 1 diabetes 
PAID-PR: Problem areas in diabetes-parents revised 
PAID-T: Problem areas in diabetes – teen version 
QoL: Quality of life 
RCT: Randomized controlled trial 
SC: Standard care 
T1D: Type 1 diabetes 
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